Program for all days

Better Kidney Health

The Interconnected Kidney

The Kidney Losing Function

The Smart Kidney

Plenary Sessions

Pre-congress Courses
(additional fee)

Special Sessions

Spotlight Sessions

Industry Symposia

Global Kidney Policy Forum

Welcome Reception

Topical Networking

Poster Sessions

Friday, February 7, 2025

Time	Session

9:45 a.m. 11:15 a.m.	Kidney-Cancer Intersections: Complications, Checkpoints and Abnormalities - Charting a Course IK01 GeorgiAbraham Chair abraham_georgi@yahoo.comIndiaMGM Healthcare, Chennai, India KriangTungsanga Chair kriangtungsanga@hotmail.comThailandDepartment of Medicine, Faculty of Medicine, Chulalongkorn Unviersity SanjayD'Cruz Chair sanjaydcruz@gmail.comIndiaGovernment Medical College & Hospital, Chandigarh Renal Complications of Novel Cancer Therapies: Practical Insights IK01-01 AnushreeShirali Speaker anushree.shirali@yale.eduUnited StatesYale University Immune Checkpoint Inhibitors and AKI IK01-02 MitchellRosner Speaker MHR9R@hscmail.mcc.virginia.eduUnited StatesUniveristy of Virginia Health Electrolyte Abnormalities in the Cancer Patient IK01-03 JolantaMalyszko Speaker jolmal@poczta.onet.plPolandMedical University of Warsaw, Poland Opening an Onconephrology Clinic - What Should You Be Aware of? IK01-04 KenarJhaveri Speaker Kjhaveri@northwell.eduUnited StatesNorthwell Health Q&A IK01-05 Amaltas Hall B101-A	New Directions in CKD Management: A Case-based Look at the 2024 KDIGO Guidelines. ISN-KDIGO Joint Session BKH2001 IfeomaUlasi Chair ifeoma.ulasi@unn.edu.ngNigeriaCollege of Medicine, University of Nigeria Sanjib KumarSharma Chair drsanjib@yahoo.comNepalBP Koirala Institute of Health Sciences ShubharthiKar Chair shubharthi@gmail.comBangladeshHabiganj Medical College,Bangladesh Detecting and Monitoring CKD Progression BKH2001-01 ElkeSchaeffner Speaker Elke.Schaeffner@charite.deGermanyCharité Universitätsmedizin Berlin, Germany How to Slow and Prevent Kidney and Cardiovascular Complications BKH2001-02 Magdalena Madero Speaker madero.magdalena@gmail.comMexicoChief of Nephrology, Instituto Nacional de Cardiol Managing Complex CKD Cases With Multiple Comorbidities BKH2001-03 NatashaMcIntyre Speaker Natasha.McIntyre@lhsc.on.caCanadaClinician Scientist, London Health Sciences Centre, London, Canada Quality of Life in CKD: The Role of Drug Stewardship and Symptom Management BKH2001-04 TeerawatThanachayanont Speaker tthanachayanont@gmail.comThailandBhumirajanagarindra Kidney Institute Hospital Q&A BKH2001-05 Amaltas Hall B101-B			Genetic Kidney Diseases: Current Trends and Future Perspectives. ISN-JSN Joint Session SK2001 PrabirRoy-Chaudhury Chair prabir@email.unc.eduUnited StatesUniversity of North Carolina and Salisbury VAMC Raja Ramachandran Chair drraja1980@gmail.comIndiaAssociate Professor ReikoInagi Chair inagi-r@m.u-tokyo.ac.jpJapanThe University of Tokyo Graduate School of Medicine Genetic Variants in Kidney Diseases SK2001-01 TomokoHorinouchi Speaker tomoko.hatono@gmail.comJapanDepartment of Pediatrics, Kobe University Graduate School of Medicine Molecular Data and Genetic Discoveries in Kidney Diseases SK2001-02 KrzysztofKiryluk Speaker kk473@columbia.eduUnited StatesColumbia University Trends in Diagnosing Genetic Kidney Diseases SK2001-03 EiseiSohara Speaker esohara.kid@tmd.ac.jpJapanInstitute of Science Tokyo Metabolism of Genetic Kidney Diseases (Pathogenic Podocyte Lipid Metabolism of Alport Syndrome) SK2001-04 AlessiaFornoni Speaker afornoni@med.miami.eduUnited StatesUniversity of Miami Q&A SK2001-05 Brahmkamal Hall - Plenary Hall	Hot Topics From the Tropics YN SabineKaram Chair sabinejkaram@gmail.comUnited StatesUniversity of Minnesota SourabhSharma Chair drsourabh05@gmail.comIndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India Best Abstract Winner - Basic Science: miRNA Profiling of Urinary Exosomes for Predicting Renal Outcome After Acute Kidney Injury: A Pilot Study YN-01 JaskiranKaur Oral Abstract Presenter Jaskiran265@gmail.comIndiaDepartment of Experimental Medicine and Biotechnology Best Abstract Winner - Clinical Science: Randomised Controlled Trial Comparing Rituximab to Mycophenolate Mofetil in Children and Young Adults With Steroid-Dependent Idiopathic Nephrotic Syndrome YN-02 AndreaAngeletti Oral Abstract Presenter andreaangeletti@gaslini.orgItaly Q and A YN-03 Everything You Ever Wanted to Know About Tropical Infections and the Kidney YN-04 MythriShankar Speaker mythri.nish@gmail.comIndiaInstitute of Nephrourology Challenges in the Tropics: When CKDu Becomes Less Unknown YN-05 ErangaWijewickrama Speaker erangasw@clinmed.cmb.ac.lkSri LankaFaculty of Medicine, University of Colombo Roundtable Discussion YN-06 BiancaDavidson Speaker bianca.davidson@gmail.comSouth AfricaGroote Schuur Hospital, University of Cape Town ErangaWijewickrama Speaker erangasw@clinmed.cmb.ac.lkSri LankaFaculty of Medicine, University of Colombo MythriShankar Speaker mythri.nish@gmail.comIndiaInstitute of Nephrourology SourabhSharma Speaker drsourabh05@gmail.comIndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India VivekKumar Speaker enigma165@yahoo.co.inIndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India Champa Hall 304		CKD-MBD Insights and Innovations for 2025 and Beyond: No Bone Left Uncovered LF01 ArvindBagga Chair arvindbagga@hotmail.comIndia UttaraDas Chair uttaradas806@gmail.comIndiaAll IndiaInstitute of Medical Science Mangalagiri What Should a Clinician Know About CKD-MBD in 2025? LF01-01 HanneJoergensen Speaker hsjorgensen@clin.au.dkDenmarkAarhus University CKD-MBD in Children and Young Adults: What's the Difference? LF01-02 SukanyaGovindan Speaker sukanyagovindan@gmail.comIndiaMehta Children's Hospitals and MGM healthcare, Chennai, India Progress in CKD-driven Vascular Calcification: From Bench to Bedside LF01-03 MarcVervloet Speaker Marc.Vervloet@radboudumc.nlNetherlandsRadboud University Medical center, The Netherlands How to Use Serum Biomarkers for Optimal Management of CKD-MBD LF01-04 SandroMazzaferro Speaker sandro.mazzaferro@uniroma1.itItalySapienza University of Rome, Italy Q&A LF01-05 Gulmohar Hall 302		Measuring Healthcare Transition Readiness to Adult-Focused Care Among Solid Organ Pediatric Transplant Recipients IPTA AhmedMitwallii Chair amitwalli2002@yahoo.comSaudi Arabia AnandChellappan Chair anandchellappan@aiimsnagpur.edu.inIndiaAll India Institute of Medical Sciences, Nagpur AsiriS Abeyagunawardena Chair asiriabey26@gmail.comSri LankaUniversity of Peradeniya Dharmendra singhBhadauriya Chair docdharm10@gmail.comIndia Harbir SinghKohli Chair kohlihs2009@gmail.comIndiaProfessor & Head of Nephrology, Post Graduate Institute of Medical Education & Research, Chandigarh, India IndiraAgarwal Chair indiraagarwal@cmcvellore.ac.inIndiaChristian Medical College KhalidAlhasan Chair kalhasan@ksu.edu.saSaudi Arabia RajivSinha Chair rajivsinha_in@yahoo.comIndiaProf ,Pediatrics, HOD , Division of Pediatric Nephrology, institute of Child Health,Kolkata,India RandulaRanawaka Chair rrandula@yahoo.comSri Lanka RukshanaShroff Chair Rukshana.Shroff@gosh.nhs.ukUnited KingdomMD, FRCPCH, PhD Shyam BihariBansal Chair drshyambansal@gmail.comIndiaDepartment of Nephrology, Medanta-The Medicity, Gurgaon, India Withanage Dona Vindya NandaniGunasekara Chair vindyaa@hotmail.comSri Lanka Medication Non-adherence Continuinty Care Lost in Transition IPTA-1 AhmedMitwallii Chair amitwalli2002@yahoo.comSaudi Arabia Harbir SinghKohli Chair kohlihs2009@gmail.comIndiaProfessor & Head of Nephrology, Post Graduate Institute of Medical Education & Research, Chandigarh, India KhalidAlhasan Chair kalhasan@ksu.edu.saSaudi Arabia VikasDharnidharka Speaker vikas.D@rutgers.eduUnited StatesRutgers Robert Wood Johnson Medical School Transition Tools and Efficacy IPTA-2 AsiriS Abeyagunawardena Chair asiriabey26@gmail.comSri LankaUniversity of Peradeniya RukshanaShroff Chair Rukshana.Shroff@gosh.nhs.ukUnited KingdomMD, FRCPCH, PhD Shyam BihariBansal Chair drshyambansal@gmail.comIndiaDepartment of Nephrology, Medanta-The Medicity, Gurgaon, India RupeshRaina Speaker RRaina@akronchildrens.orgUnited States What Does Transition Mean for LMIC: Challenges IPTA-3 Dharmendra singhBhadauriya Chair docdharm10@gmail.comIndia RandulaRanawaka Chair rrandula@yahoo.comSri Lanka Kar HuiNg Speaker paenkh@nus.edu.sgSingaporeDepartment of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore Multidisplinary Approach IPTA-4 AnandChellappan Chair anandchellappan@aiimsnagpur.edu.inIndiaAll India Institute of Medical Sciences, Nagpur IndiraAgarwal Chair indiraagarwal@cmcvellore.ac.inIndiaChristian Medical College Withanage Dona Vindya NandaniGunasekara Chair vindyaa@hotmail.comSri Lanka PriyaVerghese Speaker pverghese@luriechildrens.orgUnited StatesProfessor, Division Chief Q and A Kesar Hall 202		Integrating Knowledge From Large-scale Data Sets in Your Research Strategy: Introduction to the Hands-on Big Data Lab at WCN'25 SS1 MatthiasKretzler Chair kretzler@umich.eduUnited StatesUniversity of Michigan ShrutiTapiawala Chair shruti16374@gmail.comIndiaGleneagles Hospital Mumbai , Sir HN Reliance Foundation Hospital and Research Center, Mumbai Artificial and Human Intelligence Work Best Together: Pathomics in 2025 SS1-01 LauraBarisoni Speaker laura.barisoni@duke.eduUnited StatesDuke University Mapping Molecular Data Sets on Clinical Profiles SS1-02 VijiNair Speaker vijin@med.umich.eduUnited StatesUniversity of Michigan The Kidney Precision Medicine Project (KPMP) Kidney Tissue Atlas: Latest Developments SS1-03 SanjayJain Speaker sanjayjain@wustl.eduUnited StatesWashington University School of Medicine Introduction to the Hands-on Big Data Lab SS1-04 HeatherAscani Speaker ascanihk@med.umich.eduUnited StatesUniversity of Michigan NikkiBonevich Speaker bonevicn@med.umich.eduUnited StatesUniversity of Michigan VijiNair Speaker vijin@med.umich.eduUnited StatesUniversity of Michigan Kumudini Hall 301	Planetary and Kidney Health: It is a Two-Way Journey BKH01 GermaineWong Chair germaine.wong@health.nsw.gov.auAustraliaUniversity of Sydney MariaPippias Chair maria.pippias@bristol.ac.ukUnited KingdomUniversity of Bristol SundararamanSwaminathan Chair swami@iisc.ac.inIndia People, the Planet, and Nephrology - the Impact of Environmental Change on Kidney Health BKH01-01 Giorgina BarbaraPiccoli Speaker GBPICCOLI@YAHOO.ITFranceCentre Hospitalier Le Mans How to Develop a Roadmap for Environmentally Sustainable Kidney Care BKH01-02 KatherineBarraclough Speaker katherine.barraclough@mh.org.auAustraliaMelbourne Health How Do I Make My Dialysis Unit More Environment-friendly? BKH01-03 TanujLamech Speaker tanujlamech@gmail.comIndiaSRM Medical College Hospital and Research Centre What Will Kidney Care Look Like 25 Years From Now? The Role of Future Generations BKH01-04 Winston Wing ShingFung Speaker winstonwsfung@hotmail.comHong Kong, ChinaPrince of Wales Hospital, Hong Kong Q&A BKH01-05 Neelkamal Hall 305			State of the Art Insights Into Pregnancy and Pediatric Thrombotic Microangiopathies IK1001 ArvindBagga Chair arvindbagga@hotmail.comIndia DavidKavanagh Chair David.Kavanagh@newcastle.ac.ukUnited KingdomNational Renal Complement Therapeutics Centre VinayRathore Chair vinayrathoredm@aiimsraipur.edu.inIndiaAll India Institute of Medical Sciences- Raipur Outcomes From the ISN Haemolytic Uraemic Syndromes Forum: A Comprehensive Review IK1001-01 DavidKavanagh Speaker David.Kavanagh@newcastle.ac.ukUnited KingdomNational Renal Complement Therapeutics Centre Differential Diagnosis and Treatment of TMAs in Pregnancy IK1001-02 ShilpanjaliJesudason Speaker shilpa.jesudason@sa.gov.auAustraliaRoyal Adelaide Hospital and University of Adelaide, Australia Factor H Autoantibodies in aHUS IK1001-03 AditiSinha Speaker aditisinhaaiims@gmail.comIndiaDepartment of Pediatrics, All India Institute of Medical Sciences aHUS in Paediatric Populations IK1001-04 Lap Tak Alison MA Speaker maalison2000@gmail.comHong Kong, ChinaHong Kong Children\'s Hospital Q&A IK1001-05 Parijat Hall 201
11:15 a.m. 12 p.m.	Big Data Lab 1 - Your Gateway to Transcriptomic Analysis in Kidney Disease Research: Nephroseq LAB-01 Big Data Lab								Industry Spotlight Session SPOT-I-1 Spotlight One (Exhibition)
11:45 a.m. 12:45 p.m.	Plenary Session 2: Mathematics as a Microscopy: Modeling Kidney Disease (Anita Layton, Canada) PL2 AgnesFogo Chair agnes.fogo@vanderbilt.eduUnited States SabineKaram Chair sabinejkaram@gmail.comUnited StatesUniversity of Minnesota Shyam BihariBansal Chair drshyambansal@gmail.comIndiaDepartment of Nephrology, Medanta-The Medicity, Gurgaon, India Roscoe Robinson Award PL2-1 ShilpanjaliJesudason Awardee shilpa.jesudason@sa.gov.auAustraliaRoyal Adelaide Hospital and University of Adelaide, Australia Mathematics as a Microscopy: Modeling Kidney Disease. Stewart Cameron Lecture PL2-2 AnitaLayton Speaker anita.layton@uwaterloo.caCanadaUniversity of Waterloo Schrier Award PL2-3 GirishBhatt Awardee drgcbhatt@gmail.comIndiaAll India Institute of Medical Sciences (AIIMS), Bhopal, M.P, India Brahmkamal Hall - Plenary Hall
1 p.m. 2 p.m.	Industry Symposium Amaltas Hall B101-A			Industry Symposium Amaltas Hall B101-B			Industry Symposium Kumudini Hall 301				Improving Renal Pathology Services in Rwanda – a Case Study on the Impact of the ISN Fellowship Program (40 years old!) SL04 RolandoClaure Del Granado Spotlight Chairperson rclaure@yahoo.comBoliviaDivision of Nephrology, Hospital Obrero No 2 - Caja Nacional de Salud, Cochabamba EtienneNtabanganyimana Spotlight Speaker ntet07@yahoo.frRwanda Ntakirutimana Gervais Spotlight Speaker gentaki2000@yahoo.frRwanda SantoshVarughese Spotlight Speaker santosh@cmcvellore.ac.inIndiaChristian Medical College Vellore SwarnalataGowrishankar Spotlight Speaker swarnalatag@gmail.comIndia Spotlight One (Exhibition)			ISN Community Film Event SL05 MarinaWainstein Chair marinawainstein@outlook.comArgentinaAcademia Nacional de Medicina de Buenos Aires Spotlight Two (Amphitheatre, level 5)
1:30 p.m. 2:15 p.m.	Glomerular Disease Jeopardy SL06 Spotlight One (Exhibition)								What Can Be Achieved in the Sister Center Partnerships? SL05A RukshanaShroff Spotlight Chairperson Rukshana.Shroff@gosh.nhs.ukUnited KingdomMD, FRCPCH, PhD GirishBhatt Spotlight Speaker drgcbhatt@gmail.comIndiaAll India Institute of Medical Sciences (AIIMS), Bhopal, M.P, India Pukar ChandraShrestha Spotlight Speaker pcshrestha@yahoo.co.ukNepal SUSANUTHUP Spotlight Speaker uthupsusan5@gmail.comIndia Spotlight Two (Amphitheatre, level 5)
2:15 p.m. 3:45 p.m.	Xenotransplantation - the Brave New World of Farm to Clinic SK01 Christoph Wanner Chair wanner_c@ukw.deGermanyUniversity SishirGang Chair sishirgang@hotmail.comIndia The First Pig to Human Transplant SK01-01 LeonardoRiella Speaker lriella@mgh.harvard.eduUnited StatesHarvard Medical School, Massachusetts General Hospital Infectious Challenges in Xenotransplant SK01-02 AtulHumar Speaker atul.humar@uhn.caCanadaUniversity of Toronto Ethical Challenges of Xenotransplantation SK01-03 DominiqueMartin Speaker dominique.martin@deakin.edu.auAustraliaDeakin University Q&A SK01-04 Amaltas Hall B101-A	Unraveling the Cardiovascular-Kidney-Metabolic Nexus: Making All Work Together for Kidney Care IK02 Parminder KaurJudge Chair parminder.judge@ndph.ox.ac.ukUnited KingdomUniversity of Oxford, UK VineetBehera Chair beheravineet@gmail.comIndiaConsultant Nephrologist & Professor Medicine, INHS Kalyani, Visakhapatnam Cardiovascular-Kidney-Metabolic Syndrome: What Does it Mean? IK02-01 KatherineTuttle Speaker Katherine.Tuttle@providence.orgUnited StatesUniversity of Washington School of Medicine, Division of Nephrology GLP-1 RA in Kidney Disease: Beyond T2DM Control IK02-02 BeatrizFernandez-Fernandez Speaker bfernandez@fjd.esSpainHospital Universitario Fundación Jimenez Díaz New Frontiers in CKD Therapy: Endothelin Receptor Antagonists IK02-03 Maria JoseSoler Speaker mjsoler01@gmail.comSpainHospital del Vall d´Hebron Myocardial Infarction in Kidney Disease - What Should a Nephrologist Know? IK02-04 SydneyTang Speaker scwtang@hkucc.hku.hkHong Kong, China Q&A IK02-05 Amaltas Hall B101-B			HIT! High Impact Clinical Trials – What and Why HIT1 Andrea Vichelli Chair andrea.viecelli@health.qld.gov.auAustraliaUniversity of Queensland VivekKumar Chair enigma165@yahoo.co.inIndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India Combination Effect of Finerenone and Empagliflozin in Participants With Chronic Kidney Disease and Type 2 Diabetes Using a UACR Endpoint Study (CONFIDENCE) HIT1-1 RajivAgarwal Oral Abstract Presenter ragarwal@iu.eduUnited States Results From the REGENCY Trial Assessing Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis HIT1-2 BradRovin Oral Abstract Presenter rovin.1@osu.eduUnited StatesThe Ohio State University Clinical and Safety Outcomes of Semaglutide by CKD Severity in the FLOW trial HIT1-3 KatherineTuttle Oral Abstract Presenter Katherine.Tuttle@providence.orgUnited StatesUniversity of Washington School of Medicine, Division of Nephrology Brahmkamal Hall - Plenary Hall	Bridging the Gap: PKD Research and Clinical Care Perspective. Kaplan PKD Session KAPLAN VicenteTorres Chair torres.vicente@mayo.eduUnited StatesMayo Clinic Welcome and Introduction of the Lillian Jean Kaplan Prize for PKD KAPLAN-01 VicenteTorres Speaker torres.vicente@mayo.eduUnited StatesMayo Clinic Preclinical Findings of PKD Mechanism to Therapy Designs and Testing KAPLAN-02 MarieTrudel Speaker marie.trudel@umontreal.caCanada Perspective on PKD Research and Clinical Care in India KAPLAN-03 SundararamanSwaminathan Speaker swami@iisc.ac.inIndia Roundtable Discussion KAPLAN-04 AndrewMallett Speaker andrew.mallett@health.qld.gov.auAustraliaJCU & THHS BillWang Speaker billwang1968@yahoo.comHong Kong, China MarieTrudel Speaker marie.trudel@umontreal.caCanada SundararamanSwaminathan Speaker swami@iisc.ac.inIndia Champa Hall 304		Improving Global Understanding and Achieving Equity in Peritoneal Dialysis Practices: ISN-DOPPS Joint Session LF2001 AmitGupta Chair dramitguptanephropgi@gmail.comIndiaChairman Department of Nephrology & Renal Transplantation, Apollomedics Superspeciality Hospital, Lucknow, India RitaSuri Chair rita.suri@mcgill.caCanadaMcGill University RobertoPecoits Filho Chair roberto.pecoits@arborresearch.orgUnited StatesArbor Research Collaborative for Health PDOPPS: Where Are We 10 Years Later? LF2001-01 RobertoPecoits Filho Speaker roberto.pecoits@arborresearch.orgUnited StatesArbor Research Collaborative for Health Kidney Health for Women on Peritoneal Dialysis: Insights from PDOPPS LF2001-02 EdwinaBrown Speaker e.a.brown@imperial.ac.ukUnited KingdomImperial College Healthcare NHS Trust Was the PD-First Policy in Thailand Justified? Insights From the PDOPPS LF2001-03 TalerngsakKanjanabuch Speaker golfnephro@hotmail.comThailandFaculty of Medicine, Chulalongkorn University Improving PD Use and Outcomes in Low and Middle-income Countries - Is Automated Peritoneal Dialysis the Answer? Yes LF2001-04 JeffreyPerl Speaker jeff.perl@utoronto.caCanadaSt. Michael's Hospital Improving PD Use and Outcomes in Low and Middle-income Countries - Is Automated Peritoneal Dialysis the Answer? No LF2001-05 RashaDarwish Speaker dr.rasha-darwish@hotmail.comEgyptKasr Aleiny medical school , Cairo University Q&A/Panel Discussion LF2001-06 Gulmohar Hall 302		Bridging the Clinical Gap: Sustainable Strategies and Innovative Therapies for Global Kidney Health BKH02 ErangaWijewickrama Chair erangasw@clinmed.cmb.ac.lkSri LankaFaculty of Medicine, University of Colombo Prof (Dr ) SanjeevGulati Chair sgulati2002@gmail.comIndiaExecutive Director Nephrology and Kidney Transplant, Fortis gp of Hospitals and Adjunct Professor, Manipal University Sustainable Community Approaches to Early CKD Detection BKH02-01 RonaldGansevoort Speaker r.t.gansevoort@umcg.nlNetherlandsDept. Nephrology, University Medical Center Groningen Kidney Disease Treatment Gaps Worldwide - Where Are the Solutions? BKH02-02 AdeeraLevin Speaker alevin@providencehealth.bc.caCanadaUniversity of British Columbia and Providence Health Care The Promise of Emerging Therapies in Reducing the Global Kidney Disease Burden BKH02-03 DavidWheeler Speaker d.wheeler@ucl.ac.ukUnited KingdomUniversity College London Co-opting Patients as Partners in Kidney Care: How Do We Do It? BKH02-04 ShilpanjaliJesudason Speaker shilpa.jesudason@sa.gov.auAustraliaRoyal Adelaide Hospital and University of Adelaide, Australia Co-opting Patients as Partners in Kidney Care: How Do We Do It? BKH02-05 ShyamsundarMuthuramalingam Speaker Shyamsundar.Muthuramalingam@sa.gov.auAustraliaCentral Adelaide Local Health Network Q&A BKH02-06 Kesar Hall 202		Managing Rare Kidney Diseases Across the Lifespan: From Childhood to Adulthood SK1001 Jonathan Barratt Chair jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK New Innovations and Best Practices for Rare Kidney Disease SK1001-01 Jonathan Barratt Speaker jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK How Can the CureGN and NEPTUNE Help Us Better Understand Rare Kidney Disease SK1001-02 MatthiasKretzler Speaker kretzler@umich.eduUnited StatesUniversity of Michigan Using Patient Registry Data to Fight Rare Kidney Diseases SK1001-03 DanielGale Speaker d.gale@ucl.ac.ukUnited KingdomUniversity College London Living With Rare Kidney Disease in Africa: Experiences and Challenges SK1001-04 IfeomaUlasi Speaker ifeoma.ulasi@unn.edu.ngNigeriaCollege of Medicine, University of Nigeria Q&A SK1001-05 Kumudini Hall 301	Innovative Interventions in Interventional Nephrology LF02 Arup Ratan Dutta Chair duttascomplex@gmail.comIndia CarmenTzanno Branco Martins Chair tzanno@gmail.comBrazilSLANH, ISN TusharVachharajani Chair tvachh@gmail.comUnited StatesJohn D. Dingell Veterans Affairs Medical Center / Wayne State University School of Medicine Multi-organ POCUS in AKI LF02-01 AbhilashKoratala Speaker akoratala@mcw.eduUnited States Changing Paradigms in Dialysis Vascular Access - What Should the Current Day Nephrologist Know? LF02-02 VandanaNiyyar Speaker vniyyar@emory.eduUnited StatesEmory University The Need for a Structured POCUS Program for the Nephrology Trainee LF02-03 EduardoArgaiz Speaker lalo.argaiz@gmail.comMexicoInstituto Nacional de Ciencias Médicas y Nutrición How to Set Up an Interventional Nephrology Service With Limited Resources LF02-04 MayuriTrivedi Speaker mayuritrivedi80@gmail.comIndiaSenior consultant and Head Department of Nephrology LTMG hospital,Mumbai,India Q&A LF02-05 Neelkamal Hall 305			How Do I…? Practical Approaches to Kidney Care Challenges IK2001 LilyMushahar Chair lilymushahar@gmail.comMalaysiaLily Mushahar, Hospital Tuanku Ja'afar Seremban, Malaysia SudarshanBallal Chair s.ballal@manipalhospitals.comIndiaNephrologist and Chairman, Manipal Hospitals, India, Bengaluru How Do I…Set Up and Implement Multidisciplinary Kidney Care? IK2001-03 IfeomaUlasi Speaker ifeoma.ulasi@unn.edu.ngNigeriaCollege of Medicine, University of Nigeria How Do I…Manage Kidney Transplant Recipients Who Are Losing Their Graft? IK2001-02 SunitaBavanandan Speaker sbavanandan@gmail.comMalaysiaHospital Kuala Lumpur, Malaysia How Do I…Get Pregnant With Kidney Disease? IK2001-01 SilviShah Speaker silvishah2108@gmail.comUnited StatesUniversity of Cincinnati, Ohio, United States How Do I…Conduct Immune Risk Stratification of Potential Kidney Transplant Recipients? IK2001-04 AjayKher Speaker ajay1kher@gmail.comIndiaEpitome Kidney Urology Institute And Lions Hospital, Delhi How Do I…Design and Implement Large Simple Trials? IK2001-05 MegJardine Speaker meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Q&A IK2001-06 Parijat Hall 201
3:45 p.m. 4:30 p.m.	Big Data Lab 2 - Deepen your understanding of CKD and AKI in healthy and diseased kidneys: The Kidney Precision Medicine Project (KPMP) Kidney Tissue Atlas LAB-02 Big Data Lab					Industry Spotlight Session SPOT-I-2 Spotlight One (Exhibition)						Easing the Treatment Burden: The Nurse's Role in Patient and Caregiver Support SL09 Ana Elizabeth pradofigueiredo Spotlight Chairperson anaef@pucrs.brBrazilPontifícia Universidade Católica do Rio Grande do ElaineBowes Spotlight Speaker elaine.bowes@nhs.netUnited KingdomKing's College Hospital Fatimade Figueiredo Spotlight Speaker f.defigueiredo@nhs.netUnited Kingdom Janevan der Jeugd Spotlight Speaker jane.vanderjeugd@sa.gov.auAustraliaFlinders Medical Centre, Adelaide, South Australia ZehraAydin Spotlight Speaker zehraydin@gmail.comTurkeyIstanbul Atlas University Spotlight Two (Amphitheatre, level 5)
4:15 p.m. 5:15 p.m.	CKD Screening: A Universal Necessity or a Targeted Approach? The Great Debate; ISN-ERA Special Session BKH03 AminuBello Chair aminu1@ualberta.caCanadaUniversity of Alberta HarunUr Rashid Chair rashid@bol-online.comBangladeshKidney Foundation Hospital and Research Institute VijayKher Chair kherv1968@gmail.comIndiaEpitome Kidney & Urology Institute, New Delhi Hot Debate - We Should Have Universal Screening For CKD: ISN-ERA Special Lecture - PRO BKH03-01 AlbertoOrtiz Speaker AOrtiz@fjd.esSpainIIS-Fundacion Jimenez Diaz UAM, Madrid, Spain Hot Debate - We Should Have Universal Screening For CKD: ISN-ERA Special Lecture - CON BKH03-02 GermaineWong Speaker germaine.wong@health.nsw.gov.auAustraliaUniversity of Sydney Amaltas Hall B101-A		Autoimmunity in Glomerular Diseases - Looking Beyond the Kidney SK02 MaartenTaal Chair maarten.taal1@nhs.netUnited KingdomUniversity of Nottingham ShrutiTapiawala Chair shruti16374@gmail.comIndiaGleneagles Hospital Mumbai , Sir HN Reliance Foundation Hospital and Research Center, Mumbai Anti-nephrin Antibodies - What Do We Know and What Can We Look Forward to? SK02-01 TobiasHuber Speaker t.huber@uke.deGermanyUniversity Medical Center Hamburg-Eppendorf Mechanism of IgA Deposition in the Mesangium: Implication for Novel Treatments SK02-02 Yoshihito Nihei Speaker y-nihei@juntendo.ac.jpJapanDepartment of Nephrology, Juntendo University Faculty of Medicine Lupus Nephritis: Recent Advances in Pathogenesis and New Therapeutic Approaches SK02-03 LizLightstone Speaker l.lightstone@imperial.ac.ukUnited KingdomImperial College London Q&A SK02-04 Brahmkamal Hall - Plenary Hall			Hot Debate: In This New Era of Artificial Intelligence, Do We Need Renal Pathologists? SK03 GeetikaSingh Chair ggmed22@gmail.comIndiaAll India Institute of Medical Sciences, New Delhi, India Ritambhra NadaDUSEJA Chair ritamduseja@yahoo.comIndiaPGIMER,CHANDIGARG,INDIA SuryaSeshan Chair svs2002@med.cornell.eduUnited StatesWeill Cornell Medicine Hot Debate: In This New Era of Artificial Intelligence, We No Longer Need Renal Pathologists - PRO SK03-01 KimSolez Speaker ksolez@ualberta.caCanada Hot Debate: In This New Era of Artificial Intelligence, We No Longer Need Renal Pathologists - CON SK03-02 AgnesFogo Speaker agnes.fogo@vanderbilt.eduUnited States Champa Hall 304			Real World Ethics: When It's Hard to Be Good BKH2002 DominiqueMartin Chair dominique.martin@deakin.edu.auAustraliaDeakin University Elliot KorantengTannor Chair elliotktannor@yahoo.co.ukGhanaKwame Nkrumah University of Science and Technology MadhukarMisra Chair misram@health.missouri.eduUnited StatesUniversity of Missouri Columbia, USA Introduction: the Difficulty of Translating Ethical Ideals in the Real World BKH2002-01 DominiqueMartin Speaker dominique.martin@deakin.edu.auAustraliaDeakin University Case Study 1: The Disruptive Dialysis Patient BKH2002-02 IanDittmer Speaker idittmer@adhb.govt.nzNew ZealandTe Whatu Ora - Health New Zealand Case Study 2: The Dodgy Doctor BKH2002-03 PriyaPais Speaker priyapais@gmail.comIndiaDepartment of Pediatric Nephrology, St John's Medical College, Bengaluru (Bangalore), India Case Study 3: The Insistent Family BKH2002-04 GhadaAnkawi Speaker ghadaankawi@gmail.comSaudi ArabiaKing Abdulaziz University Q and A, and Conclusion: Ethical Recommendations for Real World Practice BKH2002-05 Gulmohar Hall 302			Exploring Complement System Dynamics: C3G and IgAN SK1002 AmitGovil Chair amit.govil@uc.eduUnited StatesUniversity of Cincinnati HernánTrimarchi Chair htrimarchi@hotmail.comArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES S AnanthKarumanchi Chair SAnanth.Karumanchi@csmc.eduUnited StatesCedars-Sinai Medical Center The Complement System in C3G and IgAN: A Pathophysiologic Perspective SK1002-01 HernánTrimarchi Speaker htrimarchi@hotmail.comArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES The Complement System in C3G: Updated Therapeutic Approaches SK1002-02 DavidKavanagh Speaker David.Kavanagh@newcastle.ac.ukUnited KingdomNational Renal Complement Therapeutics Centre The Complement System in IgAN: An Updated Therapeutic Approach SK1002-03 HeatherReich Speaker Heather.Reich@uhn.caCanadaUniversity of Toronto, University Health Network Q&A SK1002-04 Kumudini Hall 301			Are Your Kidneys OK? Early CKD Detection and Key Advocacy Strategies. WKD Joint Session BKH1001 Augusto CesarSoares dos Santos Junior Chair acssjunior@hotmail.comBrazilHospital das Clinicas, UFMG; Fac Ciências Medicas LathaKumaraswami Chair info@ifkf.orgIndiaPast President, IFKF-WKA; Managing Trustee TANKER Foundation, India Primary Kidney Disease Prevention: The 8 Golden Rules BKH1001-01 DinaAbdellatif Speaker dina.abdellatif@gmail.comEgyptCairo University Hospital Proactive Kidney Health: The Return on Investment of Early Detection BKH1001-02 JosephVassalotti Speaker joseph.vassalotti@mountsinai.orgUnited StatesIcahn School of Medicine at Mount Sinai Kidney Health Across Ages: Comparing Risk Factors in Adults and Pediatrics BKH1001-03 AnnaFrancis Speaker Anna.Francis@health.qld.gov.auAustraliaUniversity of Queensland Kidney Awareness: Engaging Patients for Better Outcomes BKH1001-04 VasundharaRaghavan Speaker vasundhara.raghavan@gmail.comIndiaMember of PLAG Q&A BKH1001-05 Neelkamal Hall 305
5:15 p.m. 6 p.m.	Big Data Lab 3 - Discover the latest Spatial Biology and Digital Pathology tools and techniques specifically designed for renal research. LAB-03 Big Data Lab
5:30 p.m. 6:30 p.m.	Poster Session POS-1 Exhibition Hall					Meet the Experts Kesar Hall 202						Young Nephrologists Quiz-a-Thon III SL10 Spotlight One (Exhibition)

Saturday, February 8, 2025

Time	Session

8:30 a.m. 9:30 a.m.	Industry Symposium Amaltas Hall B101-A	Industry Symposium Champa Hall 304	Meet the Experts Kesar Hall 202	Industry Symposium Kumudini Hall 301	Industry Symposium Neelkamal Hall 305
9:45 a.m. 11:15 a.m.	Toward Complex Understanding of Kidney Function in AKI: Role of Biomarkers, Sex Differences and the Tropics; ISN-KSN Joint Session IK03 GirishNarayen Chair girishnarayan49@gmail.comIndiaChief of Nephrology division, udaiomni hospital, Hyderabad,India Hyeong CheonPark Chair amp97nody@gmail.comKorea (Republic of)Hyeong Cheon Park, Gangnam Severance Hospital, Yonsei University Prem PVarma Chair varmapp123@rediffmail.comIndiaPrincipal Director What Do We Know About the Association Between AKI and Long-Term Adverse Outcomes? IK03-01 Chi-yuanHsu Speaker Chi-yuan.Hsu@ucsf.eduUnited StatesUniversity of California, San Francisco Are Biomarkers in AKI Ready for Prime Time? IK03-02 ChiragParikh Speaker chirag.parikh@jhmi.eduUnited StatesJohns Hopkins University Community-acquired AKI in the Tropics - Is it a Different Disease? IK03-03 VivekKumar Speaker enigma165@yahoo.co.inIndiaPostgraduate Institute of Medical Education and Research, Chandigarh, India Sex as a Biological Variable in the Epidemiology of AKI IK03-04 MarliesOstermann Speaker Marlies.Ostermann@gstt.nhs.ukUnited KingdomKing's College London Q&A IK03-05 Amaltas Hall B101-A	Anemia Management: Paradigm Shift or Hype? LF03 DineshKhullar Chair drdineshkhullar@gmail.comIndia Fatiu AbiolaArogundade Chair fatiu3@yahoo.comNigeriaObafemi Awolowo University Teaching Hospitals Complex/ National Postgraduate Medical College of Nigeria MayuriTrivedi Chair mayuritrivedi80@gmail.comIndiaSenior consultant and Head Department of Nephrology LTMG hospital,Mumbai,India Guideline-based Treatment of Anaemia of CKD: What's New? LF03-01 Kai-UweEckardt Speaker kai-uwe.eckardt@charite.deGermanyDepartment of Nephrology and Medical Intensive Car HIF-PHIs: Two Sides of the Same Coin LF03-02 Chuan-MingHao Speaker chuanminghao@fudan.edu.cnChinaFudan University Huashan Hospital Iron Therapy in CKD: Moving Targets LF03-03 EviNagler Speaker evi.nagler@ugent.beBelgiumNephrology Department, Ghent University Hospital, Consequences of Iron Overload LF03-04 RobertKalyesubula Speaker rkalyesubula@gmail.comUgandaMakerere, University Q&A LF03-05 Amaltas Hall B101-B	Debunking Nephrology Myths: Insights From Global Kidney Care Leaders BKH2003 SanjayPandya Chair saveyourkidney@gmail.comIndiaConsulting Nephrologist, Wockhardt Hospital & Jalaram Hospital, Rajkot SreejithParameswaran Chair sparameswaran@outlook.comIndiaProfessor & Head, Department of Nephrology, Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry, India Revisiting Kidney Biopsies: Why More Than One Can Be Beneficial BKH2003-01 BradRovin Speaker rovin.1@osu.eduUnited StatesThe Ohio State University Genetic Testing for Kidney Disease Is Not Complicated BKH2003-02 KelsieBogyo Speaker kb3164@cumc.columbia.eduUnited StatesColumbia University Irving Medical Center Thrombotic Microangiopathy Workup: Everything You Need to Know BKH2003-03 AnujaJava Speaker ajava@wustl.eduUnited StatesWASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS Dealing With Biological Variability in Albuminuria and Creatinine BKH2003-04 SusrutWaikar Speaker swaikar@partners.orgUnited StatesBoston University Chobanian and Avedisian School of Medicine, and Boston Medical Center The Underdiagnosis of Primary Aldosteronism in Clinical Practice BKH2003-05 VivekBhalla Speaker vbhalla@stanford.eduUnited StatesDirector, Stanford Hypertension Center; Division of Nephrology, Stanford University School of Medicine Q&A BKH2003-06 Brahmkamal Hall - Plenary Hall	The ISN-KI/KIR Editorial Fellows Session: The Best of 2024/25 Articles KI/KIR1 BradRovin Chair rovin.1@osu.eduUnited StatesThe Ohio State University GermaineWong Chair germaine.wong@health.nsw.gov.auAustraliaUniversity of Sydney PierreRonco Chair pierreronco@yahoo.frFranceHôpital Tenon Kidney International in Focus: Annual Highlights KI/KIR1-01 PierreRonco Speaker pierreronco@yahoo.frFranceHôpital Tenon ISN-KI Fellows: Showcasing Excellence Part 1 KI/KIR1-02 Eugene Yu HinChan Speaker genegene.chan@gmail.comHong Kong, ChinaThe Chinese University of Hong Kong, Hong Kong Children's Hospital ISN-KI Fellows: Showcasing Excellence Part 2 KI/KIR1-03 IsabelleAyoub Speaker isabelle.ayoub@osumc.eduUnited StatesThe Ohio State University ISN-KI Fellows: Showcasing Excellence Part 3 KI/KIR1-04 ChristophKuppe Speaker ckuppe@ukaachen.deGermanyDepartment of Nephrology, RWTH University Aachen, Germany ISN-KI Fellows: Showcasing Excellence Part 4 KI/KIR1-05 GriffithPerkins Speaker griffith.perkins@adelaide.edu.auAustralia Q and A Kidney International Reports in Focus: Annual Highlights KI/KIR1-06 JaiRadhakrishnan Speaker jr55@cumc.columbia.eduUnited StatesColumbia University in the City of New York Kidney International Reports in Focus: Annual Highlights KI/KIR1-07 SumitMohan Speaker mohan.sumit@gmail.comUnited StatesColumbia University Kidney International Reports in Focus: Annual Highlights KI/KIR1-08 AnnaFrancis Speaker Anna.Francis@health.qld.gov.auAustraliaUniversity of Queensland Q and A Celebrating Excellence: Best Reviewer Awards Presentation KI/KIR1-09 BradRovin Speaker rovin.1@osu.eduUnited StatesThe Ohio State University Recognizing the Best: Basic Science Awards for Early Career Researchers KI/KIR1-10 VeronicaMiguel Speaker vmiguh00@gmail.comSpainSpanish National Centre for Cardiovascular Research Recognizing the Best: Clinical Science Awards for Early Career Researchers KI/KIR1-11 MuzamilHassan Speaker muzlamide@yahoo.comNigeriaDepartment of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria Recognizing the Best: ISN-KI Editorial Fellows Awards KI/KIR1-12 GermaineWong Speaker germaine.wong@health.nsw.gov.auAustraliaUniversity of Sydney Champa Hall 304	Pursuing Global Equitable Access to Peritoneal Dialysis: ISN-ISPD Joint Session LF2002 AdrianLiew Chair draliew2@gmail.comSingaporeMount Elizabeth Novena Hospital, Singapore AnuragGupta Chair dranuragg1@yahoo.comIndia SimonDavies Chair simonj.davies55@gmail.comUnited KingdomKeele University Peritoneal Dialysis: A Global Epidemiological Perspective LF2002-01 RajnishMehrotra Speaker rmehrotr@u.washington.eduUnited StatesUniversity of Washington What’s Stopping PD Use in South Asia? LF2002-02 PritiMeena Speaker pritimn@gmail.comIndiaAll india institute of medical sciences-Bhubaneswar International Home Dialysis Consortium (IHDC) Initiatives: Expanding Global Access to Peritoneal Dialysis LF2002-03 EdwinaBrown Speaker e.a.brown@imperial.ac.ukUnited KingdomImperial College Healthcare NHS Trust Empowering Nurses to Support Growth of Peritoneal Dialysis Programs LF2002-04 ReenaGeorge Speaker reenarachelgeorge@gmail.comIndiaChristian Medical College Vellore, Tamil Nadu, India Q&A LF2002-05 Gulmohar Hall 302	Making the Case: Investing in Kidney Care for Equity and Access BKH04 AKBhalla Chair bhallaak@yahoo.comIndiaSir Ganga Ram Hospital New Delhi ElenaZakharova Chair helena.zakharova@gmail.comRussiaElena Zakharova, Botkin Hospital, Moscow, Russia MarinaWainstein Chair marinawainstein@outlook.comArgentinaAcademia Nacional de Medicina de Buenos Aires Empowering Kidney Care Through Advocacy: Strategies and Success Stories BKH04-01 LauraSola Speaker solalaura11@gmail.comUruguayDialysis Center, CASMU-IAMPP How to Convince Your Health Minister to Invest in CKD Prevention BKH04-02 Elliot KorantengTannor Speaker elliotktannor@yahoo.co.ukGhanaKwame Nkrumah University of Science and Technology Toward Removal of Socioeconomic Inequities in Kidney Care and Better Outcomes for Children BKH04-03 ArpanaIyengar Speaker arpanaiyengar@gmail.comIndiaST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES, BANGALORE How Do We Advocate for Better Access to Kidney Transplantation Worldwide? BKH04-04 IkechiOkpechi Speaker iokpechi@ualberta.caCanadaUniversity of Alberta Q&A BKH04-05 Kumudini Hall 301	Renal Resilience - Recent Advances in Clinical Knowledge and Future Treatment of Rare Orphan Diseases; ISN-CSN Joint Session SK04 ArvindConjeevaram Chair canchi8@gmail.comIndiaHead - Nephrology Dept, Trustwell Hospitals, Bangalore DebasishBanerjee Chair dbanerje@sgul.ac.ukUnited KingdomSt George's University Hospital NHS Foundation Tr How Do I Treat Renal Complications in Patients With Sickle Cell Disease? SK04-01 ClaireSharpe Speaker claire.sharpe@nottingham.ac.ukUnited KingdomUniversity of Nottingham and King's College Hospital, London iPSCs to Model Rare Kidney Diseases for Drug Discovery: The Examples of FSGS and ADPKD SK04-02 ArielaBenigni Speaker ariela.benigni@marionegri.itItalyMario Negri Institute for Pharmacological Research, Italy Kidney Multiome-based Genetic Scorecard Reveals Convergent Coding and Regulatory Variants SK04-03 KatalinSusztak Speaker ksusztak@pennmedicine.upenn.eduUnited StatesUniversity of Pennsylvania Primary Hyperoxaluria: A Hope for Gene Therapy? SK04-04 YaacovFrishberg Speaker yaacovf@ekmd.huji.ac.ilIsrael Q&A SK04-05 Neelkamal Hall 305	Key Issues in Transplantation in India: Challenges and Opportunities. ISN-Indian SN Joint Session LF2010 AlanFernandes Almeida Chair almeidaa@gmail.comIndiaPD Hinduja Hospital & Medical Research Center, Mumbai SreelathaMelemadathil Chair drrcbabu@gmail.comIndiaGovernment Medical College, Kozhikode TB in Transplant Candidates and Recipients: Diagnosis and Treatment LF2010-01 Shyam BihariBansal Speaker drshyambansal@gmail.comIndiaDepartment of Nephrology, Medanta-The Medicity, Gurgaon, India Bringing in Personalized Medicine Approaches to Kidney Transplantation: What Is Possible LF2010-02 Harbir SinghKohli Speaker kohlihs2009@gmail.comIndiaProfessor & Head of Nephrology, Post Graduate Institute of Medical Education & Research, Chandigarh, India Kidney Transplantation in Children: What Are the Special Issues and How to Navigate Them? LF2010-03 PriyaVerghese Speaker pverghese@luriechildrens.orgUnited StatesProfessor, Division Chief Bringing Equity to Transplantation: Barriers, Challenges and Triumphs LF2010-04 NatarajanGOPALAKRISHNAN Speaker srigola751@yahoo.comIndia Q and A LF2010-05 Parijat Hall 201
11:15 a.m. 12 p.m.	Big Data Lab 4 - Link Kidney Genetics and Genomics in Experimental Research: NephQTL LAB-04 Big Data Lab	Inside iNET-CKD: Uncovering the Power of Cohort Studies to Understand Ckd Progression and Complications SL11 MaartenTaal Spotlight Chairperson maarten.taal1@nhs.netUnited KingdomUniversity of Nottingham RobertoPecoits Filho Spotlight Chairperson roberto.pecoits@arborresearch.orgUnited StatesArbor Research Collaborative for Health Introducing iNET-CKD: Harnessing Global Cohorts to Transform CKD Research MaartenTaal Spotlight Speaker maarten.taal1@nhs.netUnited KingdomUniversity of Nottingham Exploring iNET-CKD Cohorts: Key Findings from iNET-CKD Studies RobertoPecoits Filho Spotlight Speaker roberto.pecoits@arborresearch.orgUnited StatesArbor Research Collaborative for Health Collaborative Opportunities in CKD Research: Leveraging the iNET-CKD Platform AdeeraLevin Spotlight Speaker alevin@providencehealth.bc.caCanadaUniversity of British Columbia and Providence Health Care Q and A Spotlight One (Exhibition)	Artificial vs Natural Intelligence in Nephrology with the ISN Emerging Leaders SL12 ChimezieOkwuonu Spotlight Chairperson getchimezie@yahoo.comNigeriaFederal Medical Center DanielO'Hara Spotlight Chairperson daniel.ohara@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, Australia Spotlight Two (Amphitheatre, level 5)
11:45 a.m. 12:45 p.m.	Plenary Session 3: Environmental Stressors and Adaptation Mechanisms: From Marine Organism to (Kidney) Health Care (Tamar Lotan, Israel) PL3 AlessiaFornoni Chair afornoni@med.miami.eduUnited StatesUniversity of Miami Narayan Prasad Chair narayan.nephro@gmail.comIndiaSanjay gandhi Postgraduate Institute of Medical Sciences, Lucknow, India VivekanandJha Chair vjha@georgeinstitute.org.inIndiaGeorge Institute for Global Health India Alfred Newton Richards Award PL3-1 ArielaBenigni Awardee ariela.benigni@marionegri.itItalyMario Negri Institute for Pharmacological Research, Italy Environmental Stressors and Adaptation Mechanisms: From Marine Organism to (Kidney) Health Care. Claude Amiel Lecture PL3-2 TamarLotan Speaker lotant@univ.haifa.ac.ilIsraelUniversity of Haifa Fellowship Program Presentation PL3-3 VivekanandJha Chair vjha@georgeinstitute.org.inIndiaGeorge Institute for Global Health India Brahmkamal Hall - Plenary Hall
1 p.m. 2 p.m.	Industry Symposium Amaltas Hall B101-A	Industry Symposium Amaltas Hall B101-B	Industry Symposium Champa Hall 304	Industry Symposium Gulmohar Hall 302	Industry Symposium Kumudini Hall 301	Industry Symposium Neelkamal Hall 305	Industry Symposium Parijat Hall 201
1:15 p.m. 2:15 p.m.	The Kidney Tank 2.0 - The Indian Version. Joint session: ISN, NephJC and NECI SL13 DilushiWijayaratne Spotlight Chairperson dilushi_w@yahoo.comSri LankaDepartment of Clinical Medicine, University of Colombo, Sri Lanka FernandaArce Spotlight Chairperson farce@theisn.orgMexico Augusto CesarSoares dos Santos Junior Spotlight Speaker acssjunior@hotmail.comBrazilHospital das Clinicas, UFMG; Fac Ciências Medicas ManjushaYadla Spotlight Speaker manjuyadla@gmail.comIndiaProfessor and Head , Nephrology , Gandhi Medical College , HYDERABAD, INDIA MythriShankar Spotlight Speaker mythri.nish@gmail.comIndiaInstitute of Nephrourology SwapnilHiremath Spotlight Speaker shiremath@toh.caCanadaUniversity of Ottawa Spotlight One (Exhibition)
2:15 p.m. 3:45 p.m.	Is the Future Now? Precision Medicine, Omics and AI for Kidney Health SK05 JolantaMalyszko Chair jolmal@poczta.onet.plPolandMedical University of Warsaw, Poland ValentineLobo Chair valentinelobo702@gmail.comIndiaNephrology Unit, King Edward Memorial Hospital, Pune Deciphering the Molecular Development of Kidney Disease: Transition From AKI to CKD SK05-01 SanjayJain Speaker sanjayjain@wustl.eduUnited StatesWashington University School of Medicine KidGen Consortium - Integrating Genomic Medicine Into Care SK05-02 AndrewMallett Speaker andrew.mallett@health.qld.gov.auAustraliaJCU & THHS Metadata Ontology, Knowledge Integration, and Kidney Precision Medicine SK05-03 MatthiasKretzler Speaker kretzler@umich.eduUnited StatesUniversity of Michigan Kidney Health Professionals and AI - Pioneers or Passive Users? SK05-04 GirishNadkarni Speaker girish.nadkarni@mountsinai.orgUnited StatesIcahn School of Medicine at Mount Sinai and the Mount Sinai Health System Q&A SK05-05 Amaltas Hall B101-A	Is it All Fluid? Dialysis Dynamics - HD, HDF, PD LF04 Arpita Roychaudhuri Chair lahiri.arpi@gmail.comIndia DibyaSingh Shah Chair dibyasingh@hotmail.comNepalInstitute of Medicine Tribhuvan University Teaching Hospital Lori-AnnFisher Chair lori2k15@gmail.comJamaicaUniversity of the West Indies, Mona Blood Pressure Management in Dialysis: Is it All Fluid? LF04-01 SandipMitra Speaker rhea2202@aol.comUnited KingdomManchester University Hospitals and University of Manchester, UK What Is a Pragmatic Approach Toward Hemodiafiltration in a Resource-limited Setting? LF04-02 SandeepMahajan Speaker mahajansn@gmail.comIndiaAll India Institute of Medical Sciences Delhi What Adult Nephrologists Need to Know About Pediatric Dialysis LF04-03 RukshanaShroff Speaker Rukshana.Shroff@gosh.nhs.ukUnited KingdomMD, FRCPCH, PhD PD in Heart Failure LF04-04 AliAbu-Alfa Speaker abualfa@aub.edu.lbLebanonAmerican University of Beirut and Yale University Q&A LF04-05 Amaltas Hall B101-B	Looking into the Crystal Ball – Where Will We Be 5 Years from Now? SK2002 RajkumarSharma Chair rksnepho206@gmail.comIndiaDirector and Head of Department of Nephrology, Medanta Hospital, Lucknow Swetha RaniKanduri Chair svetarani@gmail.comUnited StatesOchsner Health, New Orleans, LA Evaluating Kidney Allograft Dysfunction SK2002-001 SumitMohan Speaker mohan.sumit@gmail.comUnited StatesColumbia University Advances in Glomerular Disease Treatment SK2002-02 Jonathan Barratt Speaker jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK Risk Prediction in AKI and CKD SK2002-03 NavdeepTangri Speaker ntangri@yahoo.comCanadaUniversity of Manitoba, SOGH Chronic Disease Innovation Centre Prioritizing Patient-friendly Dialysis SK2002-04 EdwinaBrown Speaker e.a.brown@imperial.ac.ukUnited KingdomImperial College Healthcare NHS Trust Glomerular Disease Diagnostics SK2002-01 SanjeevSethi Speaker sethi.sanjeev@mayo.eduUnited StatesMayo Clinic Q&A SK2002-06 Brahmkamal Hall - Plenary Hall	Understanding and Managing Renal-Respiratory Critical Conjunctions IK04 ManjushaYadla Chair manjuyadla@gmail.comIndiaProfessor and Head , Nephrology , Gandhi Medical College , HYDERABAD, INDIA Muhammad Rafiqul Alam Chair alammrdr@gmail.comBangladesh R KasiVisweswaran Chair rkasivis@yahoo.comIndiaAnanthapuri Hospitals and Research Institute, Trivandrum INDIA Acute Respiratory Distress Syndrome and the Kidney IK04-01 FaeqHusain-Syed Speaker faeq.husain-syed@innere.med.uni-giessen.deGermanyUniversity Hospital Giessen and Marburg GmbH, Giessen, Germany Cellular Plasticity in Pulmonary Fibrosis: Implications for Finding Treatment and Understanding Kidney Fibrosis IK04-02 SahajalDhooria Speaker sahajal@gmail.comIndia Managing Pulmonary Renal Syndromes - What Do the Guidelines Say? IK04-03 VladimirTesar Speaker vladimir.tesar@lf1.cuni.czCzech RepublicCharles University, Prague Pulmonary Infections and Kidney Injury in ICUs IK04-04 RolandoClaure Del Granado Speaker rclaure@yahoo.comBoliviaDivision of Nephrology, Hospital Obrero No 2 - Caja Nacional de Salud, Cochabamba Q&A IK04-05 Champa Hall 304	Navigating Pregnancy and Kidney Disease: Risks, Benefits, and Global Insights. ISN-WIN/WIN India Joint Session LF2004 LizLightstone Chair l.lightstone@imperial.ac.ukUnited KingdomImperial College London RashaDarwish Chair dr.rasha-darwish@hotmail.comEgyptKasr Aleiny medical school , Cairo University UrmilaAnandh Chair uanandh@gmail.comIndiaAmrita Hospitals, Faridabad, Delhi NCR Patient Presentation LF2004-01 Pregnancy-related AKI – a Lethal Problem LF2004-02 DIVYABAJPAI Speaker divyaa24@gmail.comIndiaProfessor, Department of Nephrology, Seth G.S.M.C. and K.E.M. Hospital, Mumbai, India aHUS in Pregnancy - What Do We Know and What Can We Do? LF2004-03 AnujaJava Speaker ajava@wustl.eduUnited StatesWASHINGTON UNIVERSITY SCHOOL OF MEDICINE IN ST. LOUIS Using Pregnancy to Initiate Long-term Kidney Care for Women LF2004-04 SaraladeviNaicker Speaker Saraladevi.Naicker@wits.ac.zaSouth AfricaUniversity of the Witwatersrand Developmental Origins of Kidney Disease: It’s All About Mother LF2004-05 KateBramham Speaker kate.bramham@kcl.ac.ukUnited KingdomKing's College London Panel Discussion with Speakers: How to Change Things? How to Raise Awareness? LF2004-06 Gulmohar Hall 302	Speed Dating with KI/KIR Editors KI/KIR2 BradRovin Chair rovin.1@osu.eduUnited StatesThe Ohio State University GermaineWong Chair germaine.wong@health.nsw.gov.auAustraliaUniversity of Sydney PierreRonco Chair pierreronco@yahoo.frFranceHôpital Tenon Introduction KI/KIR2 -1 PierreRonco Speaker pierreronco@yahoo.frFranceHôpital Tenon Translational Science/Genomics KI/KIR2-2 ChristophKuppe Speaker ckuppe@ukaachen.deGermanyDepartment of Nephrology, RWTH University Aachen, Germany KrzysztofKiryluk Speaker kk473@columbia.eduUnited StatesColumbia University Discovery Science KI/KIR2-3 ReikoInagi Speaker inagi-r@m.u-tokyo.ac.jpJapanThe University of Tokyo Graduate School of Medicine VeronicaMiguel Speaker vmiguh00@gmail.comSpainSpanish National Centre for Cardiovascular Research Clinical Trials KI/KIR2-4 BradRovin Speaker rovin.1@osu.eduUnited StatesThe Ohio State University Crossing the Lines to ‘Acceptance’ in High Impact Kidney Journals KI/KIR2-5 PierreRonco Speaker pierreronco@yahoo.frFranceHôpital Tenon SumitMohan Speaker mohan.sumit@gmail.comUnited StatesColumbia University Epidemiology/Stats/Policy Forum KI/KIR2-6 AnnaFrancis Speaker Anna.Francis@health.qld.gov.auAustraliaUniversity of Queensland GermaineWong Speaker germaine.wong@health.nsw.gov.auAustraliaUniversity of Sydney MuzamilHassan Speaker muzlamide@yahoo.comNigeriaDepartment of Medicine, Obafemi Awolowo University, Ile-Ife, Nigeria Kesar Hall 202	Next-Gen Perspectives Debate: Will AI Replace Nephrologists in the Future? YN2 AakashShingada Chair aakashshingada@gmail.comIndia KornchanokVareesangthip Chair kornchanok.ploy@gmail.comThailandSiriraj Hospital, Mahidol University, Thailand Winston Wing ShingFung Chair winstonwsfung@hotmail.comHong Kong, ChinaPrince of Wales Hospital, Hong Kong Next-Gen Perspectives Debate: Will AI Replace Nephrologists in the Future? YN2 AlejandroGarcia-Rivera Speaker garciarivera.dr@gmail.comMexicoHospital General Regional 46 IntissarHaddiya Speaker intissarhaddiya@yahoo.frMoroccoDepartment of nephrology Faculty of medicine and Pharmacy of Oujda Mohammed First University Kyung DonYoo Speaker ykd9062@gmail.comKorea (Republic of)Ulsan University Hospital, University of Ulsan College of Medicine / Deputy Director, Disaster Preparedness and Response Committee, The Korean Society of Nephrology MarinaWainstein Speaker marinawainstein@outlook.comArgentinaAcademia Nacional de Medicina de Buenos Aires Kumudini Hall 301	Advancing Global Transplant Equity: A Health-systems and Patient-centered Approach. ISN-TTS/WIT Joint session LF2003 DominiqueMartin Chair dominique.martin@deakin.edu.auAustraliaDeakin University PINAKI MUKHOPADHYAY Chair drpinaki71@yahoo.comIndiaDCH.MD.DM (Nephro, PGI Chandigarh), FICP, FISN, FASN, FRCP(London), Professor and Head, Department of Nephrology,NRS MEDICAL COLLEGE KOLKATA TobyCoates Chair toby.coates@sa.gov.auAustralia Reviewing Transplantation in Tanzania: Barriers to Expansion and Insights for Other African Countries LF2003-01 FransiaMushi Speaker fransiaarda@gmail.comTanzaniaMuhimbili University of Health and Allied Sciences The Role of Infectious Disease Expertise in Improving Utilization and Preserving Grafts LF2003-02 JonathanHand Speaker jonathan.hand@ochsner.orgUnited StatesOchsner Health Day-to-Day Challenges in Providing Kidney Replacement Therapy for Women in Low-income Countries LF2003-03 PritiMeena Speaker pritimn@gmail.comIndiaAll india institute of medical sciences-Bhubaneswar Transplantation in Thailand: In-depth Review of Current Activities and Progress LF2003-04 AdisornLumpaopong Speaker adisornuic@yahoo.comThailandOn Behalf of Thai Transplantation Society Q&A LF2003-05 Neelkamal Hall 305	What’s Next in Kidney Care Research? Innovations and Clinical Trials on the Horizon SS2 AdeeraLevin Chair alevin@providencehealth.bc.caCanadaUniversity of British Columbia and Providence Health Care Andrea Vichelli Chair andrea.viecelli@health.qld.gov.auAustraliaUniversity of Queensland Ajit singhNarula Chair narulaas@gmail.comIndia Novel Trial Designs in Nephrology: Innovations and Structures SS2-01 MegJardine Speaker meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia What’s New in Clinical Trials? SS2-02 DavidWheeler Speaker d.wheeler@ucl.ac.ukUnited KingdomUniversity College London Value of Different Outcomes in the Era of Precision Medicine SS2-03 RobertoPecoits Filho Speaker roberto.pecoits@arborresearch.orgUnited StatesArbor Research Collaborative for Health Conducting Trials in Low and Middle-income Countries SS2-04 SoumitaBagchi Speaker soumita_bagchi@yahoo.co.inIndiaProfessor, Department of Nephrology, All India Institute of Medical Sciences, New Delhi Innovations in Pediatric Nephrology Discovery and Clinical Trial Conduct SS2-05 ArpanaIyengar Speaker arpanaiyengar@gmail.comIndiaST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES, BANGALORE Q&A SS2-06 Parijat Hall 201
3:45 p.m. 4:30 p.m.	Big Data Lab 5 - Discover the Power of Single-Cell Analysis linked with Clinical Data: CELLxGENE LAB-04 Big Data Lab	Industry Spotlight Session SPOT-I-3 Spotlight One (Exhibition)	Advancing Kidney Research with Registries, Collaborative Efforts, and Impactful Stories (ISN-SharE-RR) SL15 FergusCaskey Spotlight Chairperson Fergus.Caskey@bristol.ac.ukUnited KingdomUniversity of Bristol, UK MariaPippias Spotlight Chairperson maria.pippias@bristol.ac.ukUnited KingdomUniversity of Bristol Unlocking Insights with ISN-SharE-RR: Advancing Kidney Research through Global Registries FergusCaskey Spotlight Speaker Fergus.Caskey@bristol.ac.ukUnited KingdomUniversity of Bristol, UK Driving Collaboration in Kidney Health: Toolkit and Resources from ISN-SharE-RR MariaPippias Spotlight Speaker maria.pippias@bristol.ac.ukUnited KingdomUniversity of Bristol Decisions I made while setting up the South African Renal Registry Mogamat RazeenDavids Spotlight Speaker mrd@sun.ac.zaSouth AfricaStellenbosch University and Tygerberg Hospital Panel Discussion with Fergus, Maria & Razeen Spotlight Two (Amphitheatre, level 5)
4:15 p.m. 5:15 p.m.	Hot Debate - To D or Not to D? Do All Patients With CKD Need Vitamin D Supplementation? LF05 FergusCaskey Chair Fergus.Caskey@bristol.ac.ukUnited KingdomUniversity of Bristol, UK OMKUMAR Chair dromkumar@rediffmail.comIndiaINDIRA GANDHI INSTITUTE OF MEDICAL SCIENCES, PATNA UmeshKhanna Chair ubkhanna@gmail.comIndia MD DNB (NEPHROLOGY), Hot Debate: To D or Not to D? All Patients With CKD Need Vitamin D Supplementation - PRO LF05-01 HanneJoergensen Speaker hsjorgensen@clin.au.dkDenmarkAarhus University Hot Debate: To D or Not to D? All Patients With CKD Need Vitamin D Supplementation - CON LF05-02 Mario GennaroCozzolino Speaker mario.cozzolino@unimi.itItalyUniversity of Milan Amaltas Hall B101-B	Hot Debate - The KDIGO BP Targets in CKD Are (Un)Achievable and (Un)Realistic IK05 ArpanaIyengar Chair arpanaiyengar@gmail.comIndiaST JOHN'S NATIONAL ACADEMY OF HEALTH SCIENCES, BANGALORE BeatrizFernandez-Fernandez Chair bfernandez@fjd.esSpainHospital Universitario Fundación Jimenez Díaz Venkata DakshinamurtyKaligotla Chair kvdm1954@gmail.comIndiaMahatma Sri Ramchandra Centenary Memorial Hospital, Vijayanagar Colony, Hyderabad, INDIA Hot Debate: The KDIGO BP Targets in CKD Are Unachievable and Unrealistic - PRO IK05-01 SwapnilHiremath Speaker shiremath@toh.caCanadaUniversity of Ottawa Hot Debate: The KDIGO BP Targets in CKD Are Unachievable and Unrealistic - CON IK05-02 IndranilDasgupta Speaker Indranil.Dasgupta@uhb.nhs.ukUnited KingdomConsultant Nephrologist, University Hospitals Birmingham, UK Brahmkamal Hall - Plenary Hall	Connecting Cardio-Kidney-Metabolic Dots: Holistic Approaches to Patient Care IK1002 Denis GeorgesTeuwafeu Chair d.teuwafeu@yahoo.comCameroonUniversity of Buea, Faculty of Health Sciences RobertKalyesubula Chair rkalyesubula@gmail.comUgandaMakerere, University RobertoPecoits Filho Chair roberto.pecoits@arborresearch.orgUnited StatesArbor Research Collaborative for Health A Nephrologist Perspective on the Cardio-Kidney-Metabolic Syndrome IK1002-01 JananiRangaswami Speaker nephrologymd1@gmail.comUnited StatesProfessor of Medicine, George Washington University School of Medicine Optimizing CKD Management in the Context of Diabetes and Obesity IK1002-02 RobertoPecoits Filho Speaker roberto.pecoits@arborresearch.orgUnited StatesArbor Research Collaborative for Health Combining Therapies for Cardio-Kidney-Metabolic Conditions: An Integrative Approach IK1002-03 KatherineTuttle Speaker Katherine.Tuttle@providence.orgUnited StatesUniversity of Washington School of Medicine, Division of Nephrology Q&A IK1002-04 Champa Hall 304	Implementing Nephrogenetics Across the Globe: ISN-IPNA Joint Session SK2003 LarisaPrikhodina Chair LPrikhodina@yahoo.comRussiaProfessor of Pediatrics, Chair of Division of Inherited & Acquired Kidney Diseases, Veltishev Research Clinical Institute for Pediatrics & Children Surgery, Pirogov Russian National Research Medical University NeveenSoliman Chair neveenase@yahoo.comEgyptCenter of Pediatric Nephrology and Transplantation, Kasr Al Ainy Faculty of Medicine, Cairo University TarunJeloka Chair tjeloka@yahoo.comIndiaMANIPAL HOSPITALS Mapping Nephrogenomic Variation in the Middle East SK2003-01 NeveenSoliman Speaker neveenase@yahoo.comEgyptCenter of Pediatric Nephrology and Transplantation, Kasr Al Ainy Faculty of Medicine, Cairo University Implementing Nephrogenetic Diagnostics in Low-resource Settings SK2003-02 Kar HuiNg Speaker paenkh@nus.edu.sgSingaporeDepartment of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore Comprehensive Nephrogenetic Diagnostics in Europe: Where Do We Stand in 2025? SK2003-03 Albertien M.Van Eerde Speaker a.vaneerde@umcutrecht.nlNetherlandsDepartment of Genetics, UMC Utrecht, The Netherlands Q and A SK2003-04 Gulmohar Hall 302	Seeing the Kidney Clearly: Solo Treatments and Orchestrated Care Through Evidence, Community, and Policy BKH1002 BrianPereira Chair bjgpereira@gmail.comUnited States GhadaAnkawi Chair ghadaankawi@gmail.comSaudi ArabiaKing Abdulaziz University MegJardine Chair meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Addressing Challenges: Early CKD Detection Strategies and the Role of Research and Development in Global Kidney Health BKH1002-01 AdeeraLevin Speaker alevin@providencehealth.bc.caCanadaUniversity of British Columbia and Providence Health Care A Collaborative Approach to Detecting Kidney Disease Early BKH1002-02 ThomasBlakeman Speaker tom.blakeman@manchester.ac.ukUnited KingdomThe University of Manchester Harnessing Digital Technology: Innovative Tools for Early CKD Detection and Management BKH1002-03 Chinta RamaKrishna Speaker rknephro@gmail.comIndiaChinta Rama Krishna, Vedanta Hospitals Q and A BKH1002-04 Kesar Hall 202	Kidney Disease Prediction and Prevention: Evolving Toward a Kidney Health Revolution BKH05 AlejandroGarcia-Rivera Chair garciarivera.dr@gmail.comMexicoHospital General Regional 46 AnuradhaRaman Chair ramananu48@gmail.comIndia SabineKaram Chair sabinejkaram@gmail.comUnited StatesUniversity of Minnesota Managing Kidney Disease in Diabetes - Is it the Best of Times? BKH05-01 PeterRossing Speaker Peter.Rossing@regionh.dkDenmarkSteno Diabetes Center Copenhagen Implementation of Risk Prediction Equations to Optimize CKD Care - the Present and the Future BKH05-02 NavdeepTangri Speaker ntangri@yahoo.comCanadaUniversity of Manitoba, SOGH Chronic Disease Innovation Centre Multisectoral Action for Kidney Disease Prevention BKH05-03 Sri LekhaTummalapalli Speaker lekha.tummalapalli@gmail.comUnited StatesAssistant Professor, Weill Cornell Medicine Q&A BKH05-04 Kumudini Hall 301	What Should I Do? Applying the Declaration of Istanbul Principles to Your Clinical Transplant Practice. ISN-DICG Joint Session BKH2004 KamalSud Chair kamal.sud@health.nsw.gov.auAustraliaThe University of Sydney Maria AmaliaMatamoros Chair amatamoros@cehcr.comCosta RicaCaja Costarricense del Seguro social SanjayNagral Chair sanjaynagral@gmail.comIndiaex co chair ; Declaration of Istanbul Custodian Group My Patient Wants to Travel Abroad for a Kidney Transplant BKH2004-01 JagbirGill Speaker jsgill2@me.comCanadaUniversity of British Columbia My Patient Received a Kidney Transplant Abroad BKH2004-02 RuthRahamimov Speaker ruth.rahamimov@gmail.comIsraelRabin Medical Center, Petach Tikva, Israel How to Deal With Suspicious Transplant Cases in Your Organization or Country BKH2004-03 Jonathan WalaAmeyo Speaker jonathanwala@yahoo.comKenyaKenya Renal Association From Identification to Resolution: A Guide to Managing Suspicious Transplant Cases BKH2004-04 ThomasMueller Speaker tfmueller1492@hotmail.comSwitzerlandSwisstransplant Q&A BKH2004-05 Neelkamal Hall 305	Bridging Gaps in Kidney Disease Diagnostics: Striving for Equity BKH1003 DanielO'Hara Chair daniel.ohara@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, Australia MythriShankar Chair mythri.nish@gmail.comIndiaInstitute of Nephrourology YannickNlandu Chair yannicknlandu@yahoo.frDemocratic Republic of CongoKinshasa University Hospital Panel Discussion: Featuring an Expert in Genetics BKH1003-01 Becky MingyaoMa Speaker mymbecky@gmail.comHong Kong, ChinaDivision of Nephrology, Department of Medicine, School of Clinical Medicine, University of Hong Kong Panel Discussion: Featuring a Renal Pathologist BKH1003-02 MarekKollar Speaker marek.kollar@ikem.czCzech Republic Panel Discussion: Featuring an Expert in CKD Care From India BKH1003-03 PritiMeena Speaker pritimn@gmail.comIndiaAll india institute of medical sciences-Bhubaneswar Panel Discussion:Featuring an Expert in CKD Care From Fiji BKH1003-04 Yogeshni Chandra Speaker chandra_yogi@yahoo.comFiji Panel Discussion: Featuring an Expert in CKD Care From Nigeria BKH1003-05 ChimezieOkwuonu Speaker getchimezie@yahoo.comNigeriaFederal Medical Center Q and A BKH1003-06 Parijat Hall 201
5:15 p.m. 6 p.m.	Big Data Lab 6 LAB-06 Big Data Lab
5:30 p.m. 6:30 p.m.	Poster Session POS-2 Exhibition Hall	Meet the Experts Kesar Hall 202	ISN Programs Abstract Awards SL16 TusharVachharajani Spotlight Chairperson tvachh@gmail.comUnited StatesJohn D. Dingell Veterans Affairs Medical Center / Wayne State University School of Medicine Do Transforming Growth Factor-β (TGF-β) Isoforms Predict Chronic Kidney Disease Progression Alfred JacksonMeremo Spotlight Speaker meremoal@gmail.comTanzania Epidemiology Of Vascular Access And Role Played By Nephrologists In Nepal NabinBasnet Spotlight Speaker dr.nabinbasnet@gmail.comNepal Prevalence Of Chronic Kidney Disease In Sri Lanka RajithaAbeysekera Spotlight Speaker rajithaasa55@gmail.comSri Lanka Sodium Gradient And All-Cause Mortality In Incident Maintenance Hemodialysis Patients: Results From The Monitoring Dialysis Outcomes (Mondo) Initiative Felix-MihaiMaralescu Spotlight Speaker felixmihai21@gmail.comRomania JC Virus Is Underestimated In Kidney Transplant Recipients MirhaPjanic Spotlight Speaker mirhapjanic93@gmail.comBosnia and Herzegovina Spotlight One (Exhibition)	AI in Nephrology: Hands-On Training Workshop SL17 Augusto CesarSoares dos Santos Junior Spotlight Chairperson acssjunior@hotmail.comBrazilHospital das Clinicas, UFMG; Fac Ciências Medicas HanjieZhang Spotlight Speaker Hanjie.Zhang@rriny.comUnited States PETERKOTANKO Spotlight Speaker Peter.Kotanko@rriny.comUnited States Spotlight Two (Amphitheatre, level 5)

Sunday, February 9, 2025

Time	Session

9 a.m. 10:30 a.m.	Metabolic Crossroads: Kidneys, Liver Disease, and the Gut IK06 GloriaAshuntantang Chair gloria.ash60@gmail.comCameroonUniversity of Bamenda, Cameroon Narayan Prasad Chair narayan.nephro@gmail.comIndiaSanjay gandhi Postgraduate Institute of Medical Sciences, Lucknow, India Dr Sree BhushanRaju Chair sreebhushan@hotmail.comIndia Hepatorenal Syndrome and New Treatments for AKI in Cirrhosis IK06-01 Swetha RaniKanduri Speaker svetarani@gmail.comUnited StatesOchsner Health, New Orleans, LA Do Gut Microbiota Contribute to Kidney Disease? If so, What Can We Do About it? IK06-02 GrietGlorieux Speaker GRIET.GLORIEUX@UGent.beBelgiumUGent What Should Nephrologists Know About Metabolic Dysfunction-associated Fatty Liver Disease IK06-03 Angela Yee-MoonWang Speaker angela.wang@duke-nus.edu.sgSingaporeHong Kong/Singapore Measuring Kidney Function in Liver Disease - Pitfalls and Solutions IK06-04 SmitaDivyaveer Speaker divyaveer.ss@gmail.comIndiaPOST GRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH, CHANDIGARH, INDIA Q&A IK06-05 Amaltas Hall B101-A	The Ageing Kidney: Of Neurons and Nephrons IK07 AnupmaKaul Chair anupmaneph@gmail.comIndiaSanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow , India AshwaniGupta Chair ashwani_gupta2002@yahoo.comIndia Mohamad Bassam Said Chair bmsaeed2000@yahoo.comSyrian Arab RepublicFarah Association for Child with Kidney Disease in Syria Defining Accelerated Kidney Ageing IK07-01 AlbertoOrtiz Speaker AOrtiz@fjd.esSpainIIS-Fundacion Jimenez Diaz UAM, Madrid, Spain Accelerated Biological Ageing in CKD: Drivers and Potential Therapeutic Interventions IK07-02 MotokoYanagita Speaker motoy@kuhp.kyoto-u.ac.jpJapanKyoto University The Kidney-Brain Connection IK07-03 MarionPépin Speaker marion.pepin@aphp.frFranceINSERM, CESP UMR 1018, Clinical epidemiology, Paris Saclay University, Villejuif, France/ Geriatric Department, Ambroise Paré Hospital, APHP, Versailles St Quentin University, Boulogne ,France Cognitive Impairment in Kidney Disease IK07-04 VanitaJassal Speaker vanita.jassal@uhn.caCanadaUniversity Health Network, Toronto CANADA Q&A IK07-05 Amaltas Hall B101-B		HIT! High Impact Clinical Trials – Why and How HIT2 DavidWheeler Chair d.wheeler@ucl.ac.ukUnited KingdomUniversity College London Winston Wing ShingFung Chair winstonwsfung@hotmail.comHong Kong, ChinaPrince of Wales Hospital, Hong Kong What Have We Learned From CONVINCE? HIT2-1 PeterBlankestijn Oral Abstract Presenter P.J.Blankestijn@umcutrecht.nlNetherlandsUniversity Medical Center Utrecht Design of the ZEUS Trial: Interleukin-6 Inhibition With Ziltivekimab for Cardiovascular Protection in Chronic Kidney Disease HIT2-2 VladoPerkovic Oral Abstract Presenter vlado.perkovic@unsw.edu.auAustraliaUniversity of New South Wales, Sydney, Australia A Phase 1/2 Trial of Zigakibart in IgA Nephropathy (IgAN) HIT2-3 Jonathan Barratt Oral Abstract Presenter jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK Observational Cohort With Embedded Randomized Controlled Trials to Study Pregnancy-Associated Progression of Renal Disease: A Feasibility Study of Dietary Nitrate (Beetroot Juice) to Protect Kidney Function in Pregnant Women With Chronic Kidney Disease HIT2-4 KateBramham Oral Abstract Presenter kate.bramham@kcl.ac.ukUnited KingdomKing's College London Design of Randomized Embedded Adaptive Platform Clinical Trial in South Asian Kidney Biopsy-Proven Primary Glomerular Diseases: Multi-Center, Multi-Arm and Multi-Stage HIT2-5 Selvin Sundar RajMani Oral Abstract Presenter selvinsr@gmail.comIndiaAssociate Professor in Nephrology, Christian Medical College, Vellore, India SuceenaAlexander Oral Abstract Presenter suceena@gmail.comIndiaChristian Medical College Vellore Brahmkamal Hall - Plenary Hall		Enhancing Prevention and Control of Chronic Kidney Conditions and Other Non-Communicable Diseases/Co-Morbidities Through Meaningful Involvement of Lived Experience Champions and Communities HRIDAY MonikaArora Chair monika@hriday-shan.orgIndiaHRIDAY Session Overview and Context HRIDAY-1 MonikaArora Speaker monika@hriday-shan.orgIndiaHRIDAY Pace-setting Presentation: Role of Civil Society in Promoting Leadership of Lived Experience Champions to Augment NCD Services and Programs HRIDAY-2 RadhikaShrivastav Speaker radhika@hriday-shan.orgIndia Keynote Presentation Inclusion of Chronic Kidney Diseases in India's National Programme on Prevention and Control of NCDs (NP-NCD): opportunity for enhanced community engagement HRIDAY-3 ShikhaVardhan Speaker shikha.vardhan@gov.inIndia Panel Discussion: Experience of a Lived Experience Champion in the Management of CKD and Other Underlying Conditions HRIDAY-4 Magdalena Machalska Speaker mmachalska@theisn.orgBelgium PradeepJoshi Speaker joship@who.intIndia SeemaBali Speaker seemabali2015@gmail.comIndiaHealthy India Alliance YangchenDolma Speaker yangchen_dolma@yahoo.comIndiaSenior Nursing Officer, AIIMS New Delhi Open Discussion HRIDAY-5 Summary of Session Highlights HRIDAY-6 MonikaArora Chair monika@hriday-shan.orgIndiaHRIDAY Gulmohar Hall 302		Make It Work Better for Failing Kidneys with Sustainable Care LF06 AjaySingh Chair Ajay_Singh@hms.harvard.eduUnited States ManjuriSharma Chair manjurisharma@yahoo.com IndiaProf. & Head, Dept of Nephrology, Gauhati Medical College & Hospital, Guwahati, Assam Toward a Plant-based Diet in CKD LF06-01 Juan-JesusCarrero Speaker juan.jesus.carrero@ki.seSwedenKarolinska Institutet Why Peritoneal Dialysis Uptake Is Low in Many World Regions and How Can We Fix it? LF06-02 Magdalena Madero Speaker madero.magdalena@gmail.comMexicoChief of Nephrology, Instituto Nacional de Cardiol Improving Dialysis Quality: A Hub-and-Spoke Network LF06-03 ManishaSahay Speaker drmanishasahay@gmail.comIndiaProfessor and Head, Department of Nephrology, Osmania Medical college and General hospital, Hyderabad, Telangana, India Kidney Supportive Care in a Low-resource Setting LF06-04 Nicola Wearne Speaker nicola.wearne@uct.ac.zaSouth AfricaGroote Schuur Hospital / university of Cape Town A Working Partnership - Shared Decision-making in Nephrology LF06-05 Ana Elizabeth pradofigueiredo Speaker anaef@pucrs.brBrazilPontifícia Universidade Católica do Rio Grande do Q&A LF06-06 Neelkamal Hall 305
10 a.m. 10:30 a.m.	How to Facilitate Learning Nephrology Among Medical Students, Residents and Fellows Using Hands-On Experiences SL18 Carmen ElenaCervantes Spotlight Chairperson ccervan2@jhmi.eduUnited States MarekKollar Spotlight Chairperson marek.kollar@ikem.czCzech Republic MythriShankar Spotlight Chairperson mythri.nish@gmail.comIndiaInstitute of Nephrourology Spotlight Two (Amphitheatre, level 5)
10:30 a.m. 11 a.m.	Parenthood in Nephrology: Opportunities and Challenges SL19 Spotlight Two (Amphitheatre, level 5)
11 a.m. 12 p.m.	Equitable Kidney Health- Making it Part of The Day Job SpS-Shiv GavinDreyer Chair gavin_dreyer@hotmail.comUnited KingdomBarts Health NHS Trust Time to Act on Kidney Health Inequalities in the UK SpS-Shiv-1 Shivani Sharma Speaker s.sharma10@aston.ac.ukUnited Kingdom Targeting Equitable Kidney Health Through the Global Kidney Health Atlas SpS-Shiv-2 ErangaWijewickrama Speaker erangasw@clinmed.cmb.ac.lkSri LankaFaculty of Medicine, University of Colombo Bridging the Access Gap in Rural Communities SpS-Shiv-1 RobertKalyesubula Speaker rkalyesubula@gmail.comUgandaMakerere, University Amaltas Hall B101-A		HIT! High Impact Clinical Trials – Study Design HIT3 DilushiWijayaratne Chair dilushi_w@yahoo.comSri LankaDepartment of Clinical Medicine, University of Colombo, Sri Lanka JAIPRAKASHTIWARI Chair dr_jptiwari@yahoo.inIndiaProfessor and Head, Department of Nephrology, Goa Medical College, Goa, India ;MD, DM Nephrology, FISN, FISOT Findings and Lessons from the PARADIGM Research Consensus Conference HIT3-1 AdeeraLevin Speaker alevin@providencehealth.bc.caCanadaUniversity of British Columbia and Providence Health Care Findings and Lessons from ALIGN Study Design HIT3-2 HernánTrimarchi Speaker htrimarchi@hotmail.comArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES Findings and Lessons from RESOLVE Study Design HIT3-3 MegJardine Speaker meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Findings and Lessons from LIFT Study HIT3-4 DebasishBanerjee Oral Abstract Presenter dbanerje@sgul.ac.ukUnited KingdomSt George's University Hospital NHS Foundation Tr Q and A Brahmkamal Hall - Plenary Hall		Quiz Session: Indian Society Early Career Nephrologists Quiz-01 ArunkumarSubbiah Host gmedaks@gmail.comIndiaAll India Institute of Medical Sciences, New Delhi MedhaviGautam Host gautam.medhavi@gmail.comIndiaMD, GlomCon Fellow, NephEdc Intern , ISN member , India SayaliThakare Host thakare.sayali@gmail.comIndiaSeth GSMC and KEM Hospital, Mumbai, India Gulmohar Hall 302		MedEd in the Modern Era: #NephJC at the #ISNWCN IND01 ArvindConjeevaram Chair canchi8@gmail.comIndiaHead - Nephrology Dept, Trustwell Hospitals, Bangalore Narayan Prasad Chair narayan.nephro@gmail.comIndiaSanjay gandhi Postgraduate Institute of Medical Sciences, Lucknow, India UrmilaAnandh Chair uanandh@gmail.comIndiaAmrita Hospitals, Faridabad, Delhi NCR Tweets, Skeets, and Podcasts: Harnessing 21st Century Tools for Medical Education IND01-01 CristinaPopa Speaker cristina.adriana.popa90@gmail.comRomaniaNephJC Don't Believe Everything You Read: #NephJC style Critical Appraisal IND01-02 SwapnilHiremath Speaker shiremath@toh.caCanadaUniversity of Ottawa Is A Picture Truly Worth a 1000 Words? Visual Abstracts and Infographics IND01-03 DIVYABAJPAI Speaker divyaa24@gmail.comIndiaProfessor, Department of Nephrology, Seth G.S.M.C. and K.E.M. Hospital, Mumbai, India Q and A IND01-04 Neelkamal Hall 305
12:15 p.m. 1:15 p.m.	Plenary Session 4: Diabetes and Adipocytokines (Takashi Kadowaki, Japan) PL4 MarcelloTonelli Chair cello@ucalgary.caCanadaUniversity of Calgary MasaomiNangaku Chair mnangaku@m.u-tokyo.ac.jpJapan MegJardine Chair meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia Diabetes and Adipocytokines. Brenner/Dirks Lecture PL4-1 TakashiKadowaki Speaker t-kadowaki@toranomon.kkr.or.jpJapanToranomon Hospital Message from Outgoing ISN President PL4-2 MasaomiNangaku Chair mnangaku@m.u-tokyo.ac.jpJapan Message from Incoming ISN President PL4-4 MarcelloTonelli Chair cello@ucalgary.caCanadaUniversity of Calgary Brahmkamal Hall - Plenary Hall

Thursday, February 6, 2025

Time	Session

9 a.m. 11 a.m.	Hands-on Masterclass in Nephrology: Interventional Nephrology, Dialysis, and POCUS Course - Critical Care and Kidney Biopsy INTV1 AndrewMoses Chair amoses2@northwell.eduUnited StatesLenox Hill Hospital, Northwell Health IrmaTchokhonelidze Chair irma.tchokhonelidze@gmail.comGeorgiaTbilisi State Medical University JadrankaButurović Ponikvar Chair jadranka.buturovic@mf.uni-lj.siSloveniaUniversity Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Slovenia MayuriTrivedi Chair mayuritrivedi80@gmail.comIndiaSenior consultant and Head Department of Nephrology LTMG hospital,Mumbai,India SourabhSharma Chair drsourabh05@gmail.comIndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India Case Study Part 1 and POCUS Kidney and Lungs BLUE Protocol INTV1-01 AndrewMoses Speaker amoses2@northwell.eduUnited StatesLenox Hill Hospital, Northwell Health Native and Transplanted Kidney Biopsy INTV1-02 JadrankaButurović Ponikvar Speaker jadranka.buturovic@mf.uni-lj.siSloveniaUniversity Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Slovenia MayuriTrivedi Speaker mayuritrivedi80@gmail.comIndiaSenior consultant and Head Department of Nephrology LTMG hospital,Mumbai,India CKRT vs. SLED: Pros and Cons INTV1-03 SourabhSharma Speaker drsourabh05@gmail.comIndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India Hands-on Training: Kidney Biopsy INTV1-04 JadrankaButurović Ponikvar Speaker jadranka.buturovic@mf.uni-lj.siSloveniaUniversity Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Slovenia MayuriTrivedi Speaker mayuritrivedi80@gmail.comIndiaSenior consultant and Head Department of Nephrology LTMG hospital,Mumbai,India Hands-on Training: CKRT and SLED Machine INTV1-05 SourabhSharma Speaker drsourabh05@gmail.comIndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India Hands-on Training: POCUS Kidney and Lung With BLUE Protocol INTV1-06 AndrewMoses Speaker amoses2@northwell.eduUnited StatesLenox Hill Hospital, Northwell Health HildaElena Fernandez Speaker hef2112@cumc.columbia.eduUnited States Amaltas Hall B101-A		Renal Pathology Course: Updates on Regional Diseases PATH1 CarmenAvila Casado Chair carmen.avila-casado@uhn.caCanadaUniversity of Toronto, UHN GeetikaSingh Chair ggmed22@gmail.comIndiaAll India Institute of Medical Sciences, New Delhi, India SuryaSeshan Chair svs2002@med.cornell.eduUnited StatesWeill Cornell Medicine IgA Nephropathy and IgA Vasculitis PATH1-01 MarkHaas Speaker mark.haas@cshs.orgUnited StatesCedars-Sinai Medical Center Kidney Lesions in Tropical Infections PATH1-02 AhmedKalebi Speaker drkalebi@ahmedkalebi.comKenyaDr. Kalebi Labs (DKL) Limited Controversies in Podocytopathies PATH1-03 CarmenAvila Casado Speaker carmen.avila-casado@uhn.caCanadaUniversity of Toronto, UHN Pregnancy Related Renal Disease PATH1-04 AgnesFogo Speaker agnes.fogo@vanderbilt.eduUnited States Q and A PATH1-05 Amaltas Hall B101-B		Navigating Kidney Care Symposium: From Guidelines to Practice, Personalized Care, and Quality of Life - Managing Transitions in Transplant and Promoting Adherence AHP1 Ana Elizabeth pradofigueiredo Chair anaef@pucrs.brBrazilPontifícia Universidade Católica do Rio Grande do ElaineBowes Chair elaine.bowes@nhs.netUnited KingdomKing's College Hospital ZehraAydin Chair zehraydin@gmail.comTurkeyIstanbul Atlas University Navigating Post-transplant Dialysis: What to Expect AHP1-01 AngelaJackson Speaker angela.jackson@middlemore.co.nzNew ZealandHealth New Zealand - Counties Manukau From Dialysis to Transplant: Guiding Children Through the Transition AHP1-02 Sandhya VNair Speaker sandya.asokakumar@gmail.comIndiaindian nursing council Meeting the Mark: Adherence Requirements for Transplant Success AHP1-03 Janevan der Jeugd Speaker jane.vanderjeugd@sa.gov.auAustraliaFlinders Medical Centre, Adelaide, South Australia Q&A AHP1-04 Champa Hall 304		Glomerular Disease Course: A Case-based Approach to Renal Histology and Nephrotic Syndrome GN1 AdrianLiew Chair draliew2@gmail.comSingaporeMount Elizabeth Novena Hospital, Singapore SuceenaAlexander Chair suceena@gmail.comIndiaChristian Medical College Vellore Approach to Nephrotic Syndrome GN1-01 SuceenaAlexander Speaker suceena@gmail.comIndiaChristian Medical College Vellore Case Presentation and Discussion 1 GN1-02 HeatherReich Speaker Heather.Reich@uhn.caCanadaUniversity of Toronto, University Health Network Case Presentation and Discussion 2 GN1-03 Raja Ramachandran Speaker drraja1980@gmail.comIndiaAssociate Professor Gulmohar Hall 302		Conservative Kidney Management Course: Core Principles and Symptom Management CKM1 FrankBrennan Chair fpbrennan@ozemail.com.auAustraliaSt George Hospital NandiniVallath Chair aanandini@gmail.comIndia SaraDavison Chair sara.davison@ualberta.caCanadaUniversity of Alberta Introduction to Kidney Supportive Care (KSC) and Conservative Kidney Management (CKM) CKM1-01 SaraDavison Speaker sara.davison@ualberta.caCanadaUniversity of Alberta Validating CKM: Evidence and Approaches CKM1-02 BarnabyHole Speaker barnaby.hole@bristol.ac.ukUnited KingdomUniversity of Bristol, UK Effective Strategies for Pharmacologic Pain Management in CKM CKM1-03 SaraDavison Speaker sara.davison@ualberta.caCanadaUniversity of Alberta Addressing Depression and Anxiety in CKM Patients CKM1-04 PeaceBagasha Speaker bagashap@gmail.comUgandaMulago National Referral Hospital Q&A CKM1-05 Kumudini Hall 301		Annual Review of Nephrology Course: Managing Kidney Failure NAR1 KenarJhaveri Chair Kjhaveri@northwell.eduUnited StatesNorthwell Health MitchellRosner Chair MHR9R@hscmail.mcc.virginia.eduUnited StatesUniveristy of Virginia Health New Solutions to Anemia Management in Kidney Failure: The Role of HIF-PH Inhibitors NAR1-01 JolantaMalyszko Speaker jolmal@poczta.onet.plPolandMedical University of Warsaw, Poland New Solutions to Phosphorus Control in Kidney Failure: Achieving Patient Goals NAR1-02 KrishnaswamySampathkumar Speaker drksampath@gmail.comIndiaMeenakshi Mission Hospital Improving Volume and Hypertension Control in Kidney Failure: New Approaches to a Critical Issue? NAR1-03 Angela Yee-MoonWang Speaker angela.wang@duke-nus.edu.sgSingaporeHong Kong/Singapore Q and A NAR1-04 Neelkamal Hall 305
11:30 a.m. 1:30 p.m.	Hands-on Masterclass in Nephrology: Interventional Nephrology, Dialysis, and POCUS Course - Hemodialysis and Complications INTV2 AndrewMoses Chair amoses2@northwell.eduUnited StatesLenox Hill Hospital, Northwell Health IrmaTchokhonelidze Chair irma.tchokhonelidze@gmail.comGeorgiaTbilisi State Medical University JadrankaButurović Ponikvar Chair jadranka.buturovic@mf.uni-lj.siSloveniaUniversity Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Slovenia MayuriTrivedi Chair mayuritrivedi80@gmail.comIndiaSenior consultant and Head Department of Nephrology LTMG hospital,Mumbai,India SourabhSharma Chair drsourabh05@gmail.comIndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India Case Study Part 2 and Cardiac POCUS INTV2-1 AndrewMoses Speaker amoses2@northwell.eduUnited StatesLenox Hill Hospital, Northwell Health Dialysis Adequacy: Assessing and Improving Outcomes INTV2-2 IrmaTchokhonelidze Speaker irma.tchokhonelidze@gmail.comGeorgiaTbilisi State Medical University Hemodialysis Catheter: Insertion, Exchange, Removal INTV2-3 AnilAGARWAL Speaker akagarwalmd@gmail.comUnited StatesUniversity of California San Francisco, Fresno, US Hands-on Training: HD Catheters: Insertion, Exchange, Removal INTV2-4 AnilAGARWAL Speaker akagarwalmd@gmail.comUnited StatesUniversity of California San Francisco, Fresno, US JeyarajBalasubramaniam Speaker kidneycare@yahoo.comIndiaKidney Care Centre, Tirunelveli, India Hands-on Training: HD/HDF/Home HD Machines: What are the Treatment Options? INTV2-5 IrmaTchokhonelidze Speaker irma.tchokhonelidze@gmail.comGeorgiaTbilisi State Medical University Hands-on Training: Cardiac POCUS INTV2-6 AndrewMoses Speaker amoses2@northwell.eduUnited StatesLenox Hill Hospital, Northwell Health HildaElena Fernandez Speaker hef2112@cumc.columbia.eduUnited States Amaltas Hall B101-A		Renal Pathology Course: Recent Advances in Kidney and Transplant Pathology PATH2 CarmenAvila Casado Chair carmen.avila-casado@uhn.caCanadaUniversity of Toronto, UHN GeetikaSingh Chair ggmed22@gmail.comIndiaAll India Institute of Medical Sciences, New Delhi, India SuryaSeshan Chair svs2002@med.cornell.eduUnited StatesWeill Cornell Medicine Mass Spectrometry for the Diagnosis of Renal Diseases PATH2-1 SanjeevSethi Speaker sethi.sanjeev@mayo.eduUnited StatesMayo Clinic Application of Digital Tools in Renal Pathology PATH2-2 ArvydasLaurinavicius Speaker Arvydas.Laurinavicius@vpc.ltLithuaniaVilnius University The Importance of Medullary Lesions In Kidney Biopsies PATH2-3 JorisRoelofs Speaker j.j.roelofs@amsterdamumc.nlNetherlandsAmsterdam UMC New Insights in Drug Induced Kidney Diseases PATH2-4 SuryaSeshan Speaker svs2002@med.cornell.eduUnited StatesWeill Cornell Medicine Q and A PATH2-5 Amaltas Hall B101-B		Navigating Kidney Care Symposium: From Guidelines to Practice, Personalized Care, and Quality of Life: Prevention, Diabetic Patients and Acute Care AHP2 Ana Elizabeth pradofigueiredo Chair anaef@pucrs.brBrazilPontifícia Universidade Católica do Rio Grande do ElaineBowes Chair elaine.bowes@nhs.netUnited KingdomKing's College Hospital ZehraAydin Chair zehraydin@gmail.comTurkeyIstanbul Atlas University Enhancing Acute Care: Managing Late Referral Hemodialysis AHP2-01 Ana Elizabeth pradofigueiredo Speaker anaef@pucrs.brBrazilPontifícia Universidade Católica do Rio Grande do Enhancing Acute Care: Managing Urgent Start Peritoneal Dialysis AHP2-02 ElaineBowes Speaker elaine.bowes@nhs.netUnited KingdomKing's College Hospital From Diabetes to Dialysis: Ensuring Smooth Care Transitions AHP2-03 EveNatusch Speaker eve.natusch@hbdhb.govt.nzNew ZealandNurse Practitioner Diabetes and Long-Term Conditions, Secondary Healthcare Services Better Together: Community Approaches to Preventing Chronic Kidney Disease AHP2-04 SulakshnaBharadwaj Speaker sulakshnabharadwaj@yahoo.co.inIndiaINSTITUTE OF LIVER AND BILIARY SCIENCES Q&A AHP2-05 Champa Hall 304		Glomerular Disease Course - A Case-Based Approach: Nephritic Syndrome GN2 AdrianLiew Chair draliew2@gmail.comSingaporeMount Elizabeth Novena Hospital, Singapore SuceenaAlexander Chair suceena@gmail.comIndiaChristian Medical College Vellore Approach to Nephritic Syndrome GN2-01 AdrianLiew Speaker draliew2@gmail.comSingaporeMount Elizabeth Novena Hospital, Singapore Case Presentation and Discussion 3 GN2-02 Jonathan Barratt Speaker jb81@leicester.ac.ukUnited KingdomUniversity of Leicester, Leicester, UK Case Presentation and Discussion 4 GN2-03 LizLightstone Speaker l.lightstone@imperial.ac.ukUnited KingdomImperial College London Case Presentation and Discussion 5 GN2-04 SuceenaAlexander Speaker suceena@gmail.comIndiaChristian Medical College Vellore Gulmohar Hall 302		Conservative Kidney Management Course: Navigating Symptoms and Metabolic Complications CKM2 FrankBrennan Chair fpbrennan@ozemail.com.auAustraliaSt George Hospital NandiniVallath Chair aanandini@gmail.comIndia SaraDavison Chair sara.davison@ualberta.caCanadaUniversity of Alberta Managing CKD-associated Pruritus and Restless Legs Syndrome in CKM CKM2-01 FrankBrennan Speaker fpbrennan@ozemail.com.auAustraliaSt George Hospital Tackling Fatigue and Insomnia in CKM Patients CKM2-02 AnujaDamani Speaker Anuja.damani@manipal.eduIndiaKasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal Managing Nausea and Vomiting in CKM: Best Practices CKM2-03 ClaireDouglas Speaker Claire.Douglas5@nhs.scotUnited KingdomNHS Tayside, Scotland, UK End-of-Life Transition in CKM: Care and Symptom Management CKM2-04 NandiniVallath Speaker aanandini@gmail.comIndia Managing Metabolic Complications of CKD in CKM CKM2-05 SaraDavison Speaker sara.davison@ualberta.caCanadaUniversity of Alberta Q&A CKM2-06 Kumudini Hall 301		Annual Review of Nephrology Course: Best Practices in Diabetic Kidney Disease Care NAR2 KenarJhaveri Chair Kjhaveri@northwell.eduUnited StatesNorthwell Health MitchellRosner Chair MHR9R@hscmail.mcc.virginia.eduUnited StatesUniveristy of Virginia Health Clinical Trials Overview: Focus on GLP1a, MRA, and SGLT2 NAR2-01 MaartenTaal Speaker maarten.taal1@nhs.netUnited KingdomUniversity of Nottingham SGLT2i Versus GLP1a And/or MRA Versus SGLT2i, And/or Starting All Together: What Should the Clinician Do? My Approach NAR2-02 KatherineTuttle Speaker Katherine.Tuttle@providence.orgUnited StatesUniversity of Washington School of Medicine, Division of Nephrology SGLT2i Versus GLP1a And/or MRA Versus SGLT2i, And/or Starting All Together: What Should the Clinician Do? My Approach NAR2-03 MadhukarMisra Speaker misram@health.missouri.eduUnited StatesUniversity of Missouri Columbia, USA Q and A NAR2-04 Neelkamal Hall 305
1 p.m. 2:25 p.m.	Building a CKDu Research Methodology Toolbox, part 1 i3C-1 ErangaWijewickrama Chair erangasw@clinmed.cmb.ac.lkSri LankaFaculty of Medicine, University of Colombo Study Designs to Answer Research Questions in CKDu i3C-1-01 Magdalena Madero Speaker madero.magdalena@gmail.comMexicoChief of Nephrology, Instituto Nacional de Cardiol Distinguishing CKDu From Other Kidney Diseases in Research Studies i3C-1-02 SumitMohan Speaker mohan.sumit@gmail.comUnited StatesColumbia University Q and A i3C-1-03 Javakusum Hall 303				ISN SharE-RR - Sharing Expertise to Support the Set-up of Renal Registries: Inspiration from Established Registries in South Asia SHARE RR1 FergusCaskey Chair Fergus.Caskey@bristol.ac.ukUnited KingdomUniversity of Bristol, UK MariaPippias Chair maria.pippias@bristol.ac.ukUnited KingdomUniversity of Bristol The SharE-RR Toolkit SHARE RR1-001 MariaPippias Speaker maria.pippias@bristol.ac.ukUnited KingdomUniversity of Bristol The South African Renal Registry: Re-Establishing After 20 Years' Dormancy and Recent Governance Lessons SHARE RR1-002 Mogamat RazeenDavids Speaker mrd@sun.ac.zaSouth AfricaStellenbosch University and Tygerberg Hospital The Bangladesh Renal Registry: Twenty Years Experience Covering HD, PD, and Transplant SHARE RR1-003 HarunUr Rashid Speaker rashid@bol-online.comBangladeshKidney Foundation Hospital and Research Institute The Indian Renal Registry: Establishing a Multi-centre Dialysis Registry SHARE RR1-004 SumaiyaArfin Speaker sumaiyaarfin@gmail.comIndiaThe George Institute for Global Health, India Q and A SHARE RR1-005 Kesar Hall 202				ISN Train The Trainer Program for Pregnancy and Kidney Disease - Update and Toolkit Launch SS3 MichelleHladunewich Chair michelle.hladunewich@sunnybrook.caCanadaSunnybrook Health Sciences Centre ShilpanjaliJesudason Chair shilpa.jesudason@sa.gov.auAustraliaRoyal Adelaide Hospital and University of Adelaide, Australia Welcome and Background on Obstetric Nephrology Evolution SS3-001 MichelleHladunewich Speaker michelle.hladunewich@sunnybrook.caCanadaSunnybrook Health Sciences Centre Overview of the TT Program and Toolkit Launch SS3-002 ShilpanjaliJesudason Speaker shilpa.jesudason@sa.gov.auAustraliaRoyal Adelaide Hospital and University of Adelaide, Australia Trainer Perspective SS3-003 GhadaAnkawi Speaker ghadaankawi@gmail.comSaudi ArabiaKing Abdulaziz University Trainer Perspective SS3-004 DIVYABAJPAI Speaker divyaa24@gmail.comIndiaProfessor, Department of Nephrology, Seth G.S.M.C. and K.E.M. Hospital, Mumbai, India Panel Discussion, Questions and Group Discussion SS3-005 Mogra Hall A 404
2:15 p.m. 4:15 p.m.	Hands-on Masterclass in Nephrology: Interventional Nephrology, Dialysis, and POCUS Course - Peritoneal Dialysis and Volume INTV3 AndrewMoses Chair amoses2@northwell.eduUnited StatesLenox Hill Hospital, Northwell Health IrmaTchokhonelidze Chair irma.tchokhonelidze@gmail.comGeorgiaTbilisi State Medical University JadrankaButurović Ponikvar Chair jadranka.buturovic@mf.uni-lj.siSloveniaUniversity Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Slovenia MayuriTrivedi Chair mayuritrivedi80@gmail.comIndiaSenior consultant and Head Department of Nephrology LTMG hospital,Mumbai,India SourabhSharma Chair drsourabh05@gmail.comIndiaVardhman Mahavir Medical College & Safdarjung Hospital, New Delhi, India Case Study Part 3 and VExUS Technique INTV3-1 AndrewMoses Speaker amoses2@northwell.eduUnited StatesLenox Hill Hospital, Northwell Health PD Catheter Insertion INTV3-2 KrishnaswamySampathkumar Speaker drksampath@gmail.comIndiaMeenakshi Mission Hospital Urgent Initiation of PD: Challenges and Solutions INTV3-3 BrettCullis Speaker brett.cullis@gmail.comSouth AfricaUniversity of Cape Town Hands-on Training: APD Machine Prescription Options INTV3-4 IrmaTchokhonelidze Speaker irma.tchokhonelidze@gmail.comGeorgiaTbilisi State Medical University KrishnaswamySampathkumar Speaker drksampath@gmail.comIndiaMeenakshi Mission Hospital Hands-on Training: PD Catheter Insertion INTV3-5 BrettCullis Speaker brett.cullis@gmail.comSouth AfricaUniversity of Cape Town Hands-on Training: VExUS INTV3-6 AndrewMoses Speaker amoses2@northwell.eduUnited StatesLenox Hill Hospital, Northwell Health HildaElena Fernandez Speaker hef2112@cumc.columbia.eduUnited States Case 3 INTV3-7 Amaltas Hall B101-A	Renal Pathology Course: Clinical-Pathologic Correlation Case Presentations PATH3 CarmenAvila Casado Chair carmen.avila-casado@uhn.caCanadaUniversity of Toronto, UHN GeetikaSingh Chair ggmed22@gmail.comIndiaAll India Institute of Medical Sciences, New Delhi, India SuryaSeshan Chair svs2002@med.cornell.eduUnited StatesWeill Cornell Medicine Nephrologist, Clinical Discussant - Case 1 PATH3-01 SantoshVarughese Speaker santosh@cmcvellore.ac.inIndiaChristian Medical College Vellore Case 1 PATH3-02 GeetikaSingh Speaker ggmed22@gmail.comIndiaAll India Institute of Medical Sciences, New Delhi, India Nephrologist, Clinical Discussant - Case 2 PATH3-03 SantoshVarughese Speaker santosh@cmcvellore.ac.inIndiaChristian Medical College Vellore Case 2 PATH3-04 AnilaKurien Speaker anila_abraham08@yahoo.comIndiaRenopath, Center for Renal and Urological Pathology, Chennai, India Nephrologist, Clinical Discussant - Case 3 PATH3-05 SantoshVarughese Speaker santosh@cmcvellore.ac.inIndiaChristian Medical College Vellore Case 3 PATH3-06 JorisRoelofs Speaker j.j.roelofs@amsterdamumc.nlNetherlandsAmsterdam UMC Nephrologist, Clinical Discussant - Case 4 PATH3-07 SantoshVarughese Speaker santosh@cmcvellore.ac.inIndiaChristian Medical College Vellore Case 4 PATH3-08 CarmenAvila Casado Speaker carmen.avila-casado@uhn.caCanadaUniversity of Toronto, UHN Nephrologist, Clinical Discussant - Case 5 PATH3-09 SantoshVarughese Speaker santosh@cmcvellore.ac.inIndiaChristian Medical College Vellore Case 5 PATH3-10 ArvydasLaurinavicius Speaker Arvydas.Laurinavicius@vpc.ltLithuaniaVilnius University Nephrologist, Clinical Discussant - Case 6 PATH3-11 SantoshVarughese Speaker santosh@cmcvellore.ac.inIndiaChristian Medical College Vellore Case 6 PATH3-12 MaheshaVankalakunti Speaker mahesha.vankalakunti@manipalhospitals.comIndiaManipal Hospitals, Bengaluru Amaltas Hall B101-B		Navigating Kidney Care Symposium: From Guidelines to Practice, Personalized Care, and Quality of Life: Supporting Patients at Home AHP3 Ana Elizabeth pradofigueiredo Chair anaef@pucrs.brBrazilPontifícia Universidade Católica do Rio Grande do ElaineBowes Chair elaine.bowes@nhs.netUnited KingdomKing's College Hospital ZehraAydin Chair zehraydin@gmail.comTurkeyIstanbul Atlas University How Frail Is Too Frail? Addressing Frailty in Home Hemodialysis Patients AHP3-01 RachaelWalker Speaker Rachael.walker@auckland.ac.nzNew ZealandUniversity of Auckland, New Zealand Fostering Independence: Supporting Patients to Manage Home Dialysis AV-fistulas AHP3-02 Fatimade Figueiredo Speaker f.defigueiredo@nhs.netUnited Kingdom Mastering Nutrition: Optimal Diet for Managing Diabetic Kidney Disease AHP3-03 GurdeepKaur Speaker gur1305@gmail.comIndiaMSc, RD Q&A AHP3-04 Champa Hall 304		Glomerular Disease Course: Case-based Approach to Rapidly Progressive Glomerulonephritis and Glomerular Diseases in Acute Kidney Injury GN3 AdrianLiew Chair draliew2@gmail.comSingaporeMount Elizabeth Novena Hospital, Singapore SuceenaAlexander Chair suceena@gmail.comIndiaChristian Medical College Vellore Approach to Rapidly Progressive Glomerulonephritis GN3-01 Raja Ramachandran Speaker drraja1980@gmail.comIndiaAssociate Professor Case Presentation and Discussion 6 GN3-02 HernánTrimarchi Speaker htrimarchi@hotmail.comArgentinaHOSPITAL BRITÁNICO DE BUENOS AIRES Case Presentation and Discussion 7 GN3-03 Muh GeotWong Speaker muhgeot.wong@sydney.edu.auAustralia Case Presentation and Discussion 8 GN3-04 AdrianLiew Speaker draliew2@gmail.comSingaporeMount Elizabeth Novena Hospital, Singapore Gulmohar Hall 302		Conservative Kidney Management Course: Shared Decision-making, Communication Skills and Capacity Building for End-of-Life Care CKM3 FrankBrennan Chair fpbrennan@ozemail.com.auAustraliaSt George Hospital NandiniVallath Chair aanandini@gmail.comIndia SaraDavison Chair sara.davison@ualberta.caCanadaUniversity of Alberta Shared Decision-making and Cultural Considerations in CKM CKM3-01 SaharKoubar Speaker skoubar@umn.eduUnited StatesUniversity of Minnesota Essential Communication Skills and Advance Care Planning in CKM (Interactive Workshop) CKM3-02 AmarBansal Speaker bansalad@upmc.eduUnited StatesUniversity of Pittsburgh School of Medicine Practical Challenges in Implementing CKM: Cultural and Resource Considerations From India CKM3-03 NandiniVallath Speaker aanandini@gmail.comIndia Q&A CKM3-04 Kumudini Hall 301		Annual Review of Nephrology Course: Electrolyte Management in the ICU NAR3 KenarJhaveri Chair Kjhaveri@northwell.eduUnited StatesNorthwell Health MitchellRosner Chair MHR9R@hscmail.mcc.virginia.eduUnited StatesUniveristy of Virginia Health Approaches to the Patient with Severe Hyponatremia and Acute Kidney Injury NAR3-01 MitchellRosner Speaker MHR9R@hscmail.mcc.virginia.eduUnited StatesUniveristy of Virginia Health Approaches to Severe Hypercalcemia NAR3-02 KenarJhaveri Speaker Kjhaveri@northwell.eduUnited StatesNorthwell Health Approaches to Severe Hyperkalemia NAR3-03 KSNayak Speaker drksnayak@gmail.comIndiaVirinchi Hospitals Q and A NAR3-04 Neelkamal Hall 305		Professor Donal O'Donoghue Global Kidney Policy Forum: Opening Remarks and Setting the Scene PF1 IfeomaUlasi Chair ifeoma.ulasi@unn.edu.ngNigeriaCollege of Medicine, University of Nigeria Opening Remarks PF1-01 IfeomaUlasi Chair ifeoma.ulasi@unn.edu.ngNigeriaCollege of Medicine, University of Nigeria Patient Testimony: Living with a Kidney Disease PF1-02 VikramVuppala Speaker vikram@nephroplus.comIndiaNephroPlus Parijat Hall 201
2:35 p.m. 4 p.m.	Building a CKDu Research Methodology Toolbox, part 2 i3C-2 ErangaWijewickrama Chair erangasw@clinmed.cmb.ac.lkSri LankaFaculty of Medicine, University of Colombo What Should We Measure to Identify Disease in CKDu Research? i3C-2-01 BenCaplin Speaker b.caplin@ucl.ac.ukUnited KingdomUniversity College London How Can Kidney Biopsies Provide Causal Insight Into CKDu? i3C-2-02 ShuchiAnand Speaker sanand2@stanford.eduUnited States Q and A Javakusum Hall 303						Professor Donal O'Donoghue Global Kidney Policy Forum: Local Voices, Global Impact: Tackling Kidney Health Challenges in India PF2 VivekanandJha Chair vjha@georgeinstitute.org.inIndiaGeorge Institute for Global Health India Introducing Local Voices PF2-01 VivekanandJha Chair vjha@georgeinstitute.org.inIndiaGeorge Institute for Global Health India Kidney Health in India: A Comprehensive Overview PF2-02 SanghamitraPati Speaker drsanghamitra12@gmail.comIndiaAdditional Director General, ICMR, New Delhi Collective Action Towards Integrated Care: Learning from National NCD Program PF2-03 MonikaArora Speaker monika@hriday-shan.orgIndiaHRIDAY Kidney Health in India: Importance of Measurement, Quality Assurance, and Registries PF2-04 ManishaSahay Speaker drmanishasahay@gmail.comIndiaProfessor and Head, Department of Nephrology, Osmania Medical college and General hospital, Hyderabad, Telangana, India Home Dialysis: Navigating Challenges and Opportunities PF2-05 Magdalena Madero Speaker madero.magdalena@gmail.comMexicoChief of Nephrology, Instituto Nacional de Cardiol Q and A PF2-05 Parijat Hall 201
2:45 p.m. 4:05 p.m.	ISN SharE-RR - Sharing Expertise to Support the Set-up of Renal Registries: Using Registries to Support Clinical Trials SHARE RR2 MegJardine Chair meg.jardine@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, University of Sydney, Australia ShilpanjaliJesudason Chair shilpa.jesudason@sa.gov.auAustraliaRoyal Adelaide Hospital and University of Adelaide, Australia Using Registry Data in Trials: Lessons on Patient Reported Outcomes from SWIFT in Australia SHARE RR2-001 RachaelMorton Speaker rachael.morton@sydney.edu.auAustraliaNHMRC Clinical Trials Centre, The University of Sydney Using Registry Data in Trials: Defining Measures of Kidney Function in Observational Studies Using Routine Health Care Data SHARE RR2-002 Juan-JesusCarrero Speaker juan.jesus.carrero@ki.seSwedenKarolinska Institutet Using Registry Data in Trials: Lessons from Tackling AKI, H4RT, and Prepare for Kidney Care in the UK SHARE RR2-003 FergusCaskey Speaker Fergus.Caskey@bristol.ac.ukUnited KingdomUniversity of Bristol, UK Q and A SHARE RR2-004 Kesar Hall 202
3:20 p.m. 4:05 p.m.	Professor Donal O'Donoghue Global Kidney Policy Forum: From Barriers to Solutions: Advancing Access to Kidney Care Across the Region PF3 UrmilaAnandh Chair uanandh@gmail.comIndiaAmrita Hospitals, Faridabad, Delhi NCR Introducing Voices from the Region PF3-01 UrmilaAnandh Chair uanandh@gmail.comIndiaAmrita Hospitals, Faridabad, Delhi NCR Kidney Health in the Region: Trends, Challenges, and WHO Initiatives for Improved Care PF3-02 NalikaGunawardena Speaker gunawardenan@who.intIndiaWHO South-East Asia Regional Office From Access to Accountability: Lessons from Thailand's Case Study on Kidney Care Policies PF3-03 YotTeerawattananon Speaker yot.t@hitap.netThailandHITAP The Role of Public-Private Partnerships in Dialysis Care and the Impact of Climate Change on Kidney Health in Bangladesh PF3-04 Kazi ShahnoorAlam Speaker kshahnoor@yahoo.comBangladeshProfessor of Nephrology National Institute of Kidney Diseases and Urology, Dhaka, Bangladesh. Sri Lanka: Tackling the Socio-Economic Determinants of Chronic Kidney Disease of Unknown Etiology (CKDu) PF3-05 DilushiWijayaratne Speaker dilushi_w@yahoo.comSri LankaDepartment of Clinical Medicine, University of Colombo, Sri Lanka Community-Based Screening through the Kidney Care Network in Nepal PF3-06 Sanjib KumarSharma Speaker drsanjib@yahoo.comNepalBP Koirala Institute of Health Sciences Q and A PF3-07 Parijat Hall 201
4:05 p.m. 4:15 p.m.	Professor Donal O'Donoghue Global Kidney Policy Forum: Closing Remarks and Next Steps PF4 IfeomaUlasi Chair ifeoma.ulasi@unn.edu.ngNigeriaCollege of Medicine, University of Nigeria Closing Remarks PF4-01 IfeomaUlasi Chair ifeoma.ulasi@unn.edu.ngNigeriaCollege of Medicine, University of Nigeria Advancing Kidney Health: Insights from Patient Advocates PF4-02 VasundharaRaghavan Speaker vasundhara.raghavan@gmail.comIndiaMember of PLAG Parijat Hall 201
4:30 p.m. 6 p.m.	Plenary Session 1 and WCN'25 Opening Ceremony OCPL1 Welcome and ISN Presidential Address OCPL-1 MasaomiNangaku Speaker mnangaku@m.u-tokyo.ac.jpJapan Science with a Purpose: Equity, Accountability and Sustainability in Kidney Care (Panel Discussion) OCPL-2 LizLightstone Moderator l.lightstone@imperial.ac.ukUnited KingdomImperial College London GautamiTadimalla Speaker gtadimalla@gmail.comIndiaLife Again Foundation NicoleScholes-Robertson Speaker nicole.scholes-robertson@sydney.edu.auAustraliaThe University of Sydney RadhikaCoomaraswamy Speaker rcoomaraswamy@yahoo.comSri LankaFormer Under Secretary General of the United Nations Congress Welcome by the Indian Society of Nephrology OCPL-3 Shyam BihariBansal Speaker drshyambansal@gmail.comIndiaDepartment of Nephrology, Medanta-The Medicity, Gurgaon, India Brahmkamal Hall - Plenary Hall
6:45 p.m. 7:30 p.m.	Spotlight on Global Kidney Health: Interactive Mapping and Key Insights SL01 AminuBello Spotlight Chairperson aminu1@ualberta.caCanadaUniversity of Alberta ISN-GKHA: Advancing Global Kidney Health – Updates and Achievements SL01-01 AminuBello Spotlight Speaker aminu1@ualberta.caCanadaUniversity of Alberta Insights into Global Kidney Health Disparities: A Regional Perspective Using the Interactive Map SL01-02 ErangaWijewickrama Spotlight Speaker erangasw@clinmed.cmb.ac.lkSri LankaFaculty of Medicine, University of Colombo The ISN-GKHA Interactive Map: Bridging Gaps Through Data-Driven Action SL01-03 SomkanyaTungsanga Spotlight Speaker s.tungsanga@gmail.comCanada Spotlight One (Exhibition)						Spotlight on How To Make Your Renal Unit Green ELP SL01A Winston Wing ShingFung Spotlight Chairperson winstonwsfung@hotmail.comHong Kong, ChinaPrince of Wales Hospital, Hong Kong DIVYABAJPAI Spotlight Speaker divyaa24@gmail.comIndiaProfessor, Department of Nephrology, Seth G.S.M.C. and K.E.M. Hospital, Mumbai, India EhabHafiz Spotlight Speaker dr_ehabosama@yahoo.comEgyptTheodor Bilharz Research Institute Winston Wing ShingFung Spotlight Speaker winstonwsfung@hotmail.comHong Kong, ChinaPrince of Wales Hospital, Hong Kong Spotlight Two (Amphitheatre, level 5)